geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 39435

Chapter 39435 provides bibliographic information on scholary research in geography and in the life sciences.



CD48 monoclonal antibody K31 for bone marrow transplantation. Progress in Clinical and Biological Research 377: 441-447

CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target. Current Opinion in Biotechnology 2(4): 622-633

CD5 (Ly-1)-negative, conventional splenic B cells make a substantial contribution to the bromelain plaque-forming cell response in CBA and BW mice. Immunology 69(4): 515-518

CD5 B Cells in Development and Disease. Proceedings of a conference. June 3-6, 1991, Palm Beach Gardens, Florida. Annals of the New York Academy of Sciences 651: 1-601

CD5 B cells. Potential role in the (auto)immune responses to Trypanosoma cruzi infection. Annals of the New York Academy of Sciences 651: 557-563

CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn. Proceedings of the National Academy of Sciences of the United States of America 89(19): 9311-9315

CD5 and CD21 molecules are a functional unit in the cell/substrate adhesion of B-chronic lymphocytic leukemia cells. European Journal of Immunology 18(1): 89-96

CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia. Blood 75(7): 1518-1524

CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of disease. American Journal of Surgical Pathology 16(2): 130-137

CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex. Proceedings of the National Academy of Sciences of the United States of America 89(14): 6368-6372

CD5 mRNA expression and auto-antibody production in early human B cells immortalized by EBV. Scandinavian Journal of Immunology 31(3): 269-274

CD5 negative IGM rheumatoid factor B cells in B-chronic lymphocytic leukemia and benign mixed cryoglobulinemia. Leukemia & Lymphoma 7(1-2): 55-62

CD5 positive B cells in peripheral blood and lymph nodes in rheumatoid arthritis. Journal of Clinical Pathology 44(1): 85-86

CD5 positive B lymphocytes: a link between autoimmunity and B-cell oncogenesis. Anticancer Research 8(4): 707-710

CD5 positive and negative B-CLL. Evidence supporting phenotypic heterogeneity in B-chronic lymphocytic leukemia (B-CLL). Annals of the New York Academy of Sciences 651: 470-473

CD5 positive immunoregulatory B cell subsets. American Journal of Hematology 28(4): 276-278

CD5 positive immunoregulatory B cells in spleen populations from multiple myeloma patients. American Journal of Hematology 37(3): 163-166

CD5 positivity on peripheral blood B lymphocytes in patients with primary Sjögren's syndrome. Allergologia et Immunopathologia 18(2): 75-78

CD5+ B cells and CD4-8-T cells in neuroimmunological diseases. Journal of Neuroimmunology 32(2): 123-132

CD5+ B cells and naturally occurring autoantibodies in cancer patients. Clinical and Experimental Immunology 85(3): 418-423

CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease. Digestive Diseases and Sciences 37(9): 1390-1395

CD5+ B cells as precursors of CD5- IgG anti-DNA antibody-producing B cells in autoimmune-prone NZB/W F1 mice. Annals of the New York Academy of Sciences 651: 576-578

CD5+ B cells from bovine leukemia virus infected cows are activated cycling cells responsive to interleukin 2. Leukemia 6(4): 304-309

CD5+ B cells in autoimmune disease and lymphoid malignancy. Clinical Immunology and Immunopathology 59(2): 173-186

CD5+ B cells in myasthenia gravis. Clinical correlations. Annals of the New York Academy of Sciences 651: 586-587

CD5+ B cells in normal newborns and infants, and in those with HIV and intrauterine infections. Annals of the New York Academy of Sciences 651: 572-575

CD5+ B lymphocytes. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 197(3): 226-241

CD5+ B lymphocytes and T-cell subsets in a case of juvenile rheumatoid arthritis. Annals of the New York Academy of Sciences 651: 564-569

CD5+ B lymphocytes and other lymphocyte subsets in primary Sjögren's syndrome. Netherlands Journal of Medicine 40(3-4): 158-164

CD5+ B lymphocytes correspond to generalist lymphocytes predicted by a computational model of affinity maturation. Journal of Theoretical Biology 154(3): 399-401

CD5+ B lymphocytes in high-risk islet cell antibody-positive and newly diagnosed IDDM subjects. Diabetes 40(10): 1314-1318

CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis. Journal of Rheumatology 17(6): 833-835

CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunology Today 10(11): 364-368

CD5+ B-lymphocytes are as dependent on T-helper cells and as responsive to T-suppressor cells in pokeweed mitogen-stimulated activation as conventional CD5- B-lymphocytes. Scandinavian Journal of Immunology 33(4): 387-392

CD5+ peritoneal B cells express high levels of membrane, but not secretory, C mu mRNA. Journal of Immunology 146(10): 3639-3645

CD5+, CD11C+, trap-positive chronic lymphocytic leukemia/prolymphocytic leukemia. Blood 80(4): 1095-1096

CD5+, CD11c+, CD20+ hairy cell leukemia. Blood 77(7): 1617-1619

CD5+, CD7+, and CD19+ non-Hodgkin's lymphoma in a child. Japanese Journal of Clinical Hematology 32(2): 137-141

CD5+B cells in rheumatoid arthritis and Sjögren's syndrome. Clinical and Experimental Rheumatology 8 Suppl 5: 67-68

CD5+B in rheumatoid arthritis. Annals of the New York Academy of Sciences 651: 540-550

CD5-T lymphocytes in renal transplant recipients. Clinical and Laboratory Haematology 13(4): 335-340

CD5-expressing B lymphocytes in the blood and salivary glands of patients with primary Sjögren's syndrome. Journal of Autoimmunity 1(2): 185-194

CD5-like phorbol-ester responsiveness in conventional B cells activated through surface immunoglobulin. Annals of the New York Academy of Sciences 651: 176-178

CD5-negative cell mediated experimental hypersensitivity pneumonitis. American Review of Respiratory Disease 145(5): 1185-1190

CD5-positive B cells after T cell depleted bone marrow transplantation. Clinical and Experimental Immunology 68(3): 662-668

CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies. American Journal of Pathology 136(4): 809-816

CD5-positive B-cells of the fetal and adult spleen lymphoid tissue: an immunophenotypical study. Verhandlungen der Deutschen Gesellschaft für Pathologie 74: 155-158

CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis. European Journal of Immunology 22(3): 791-797

CD59 functions as a signal-transducing molecule for human T cell activation. Journal of Immunology 146(12): 4092-4098

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. Journal of Experimental Medicine 170(3): 637-654

CD5dim peripheral blood lymphocytes proliferate to exogenous IL-2 in the absence of antigen and kill in an NK-like manner. Cellular Immunology 130(2): 389-400

CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proceedings of the National Academy of Sciences of the United States of America 88(14): 6224-6228

CD62/P-selectin recognition of myeloid and tumor cell sulfatides. Cell 67(1): 35-44

CD63/Pltgp40: a platelet activation antigen identical to the stage-specific, melanoma-associated antigen ME491. Blood 78(2): 280-284

CD66 identifies a neutrophil-specific epitope within the hematopoietic system that is expressed by members of the carcinoembryonic antigen family of adhesion molecules. Blood 78(1): 63-74

CD66 monoclonal antibodies recognize a phosphotyrosine-containing protein bearing a carcinoembryonic antigen cross-reacting antigen on the surface of human neutrophils. Journal of Immunology 148(3): 852-860

CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. Journal of Cell Biology 118(2): 457-466

CD68 antigen expression by human retinal pigment epithelial cells. Experimental Eye Research 55(1): 21-28

CD69 is expressed on Daudi cells in response to interferon-alpha. Cytokine 4(1): 36-43

CD69 molecule in human neutrophils: its expression and role in signal-transducing mechanisms. Cellular Immunology 142(1): 186-196

CD69, an early activation antigen on lymphocytes, is constitutively expressed by human epidermal Langerhans cells. Journal of Investigative Dermatology 98(5): 771-776

CD7 (+) stem cell leukemia presenting different phenotypes in lymph node and bone marrow. Japanese Journal of Clinical Hematology 33(8): 1046-1051

CD7 (GP40) false-positive acute myelogenous leukemia and promyelocytic leukemia cell line HL-60. Leukemia Research 15(4): 277-278

CD7 augments T cell proliferation via the interleukin-2 autocrine pathway. Cellular Immunology 141(1): 189-199

CD7 expression in malignant pleural mesothelioma. Japanese Journal of Cancer Research 83(7): 680-683

CD7 false-positive acute myelogenous leukemia and promyelocytic leukemia cell line HL-60: characterization of CD7 epitopes by four monoclonal antibodies. American Journal of Hematology 38(1): 72-74

CD7+ acute non-lymphocytic leukemia: evidence for an early multipotential progenitor. Leukemia Research 14(1): 23-26

CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood 73(2): 381-390

CD7+, CD4-/CD8- acute leukemia with t(11;14)(p15;q11) in a child. Cancer Genetics and Cytogenetics 56(2): 171-176

CD7- T cells in rheumatoid arthritis. Arthritis and Rheumatism 35(6): 615-624

CD7-positive acute leukemia lacking T cell receptor gene rearrangements and terminal deoxynucleotidyl transferase expression suggesting pre-T cell origin. American Journal of Hematology 32(3): 212-216

CD7-positive acute myeloid leukemia: further evidence of cellular immaturity. Journal of Cancer Research and Clinical Oncology 118(5): 386-388

CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone. Diabetes 41(12): 1603-1608

CD8 expression alters the fine specificity of an alloreactive MHC class I-specific T hybridoma. International Immunology 4(4): 455-466

CD8 gamma delta cells: presence in the adult rat thymus and generation in vitro from CD4-/CD8- thymocytes in the presence of interleukin 2. Cytokine 3(6): 598-608

CD8 hyperlymphocytosis in HIV infection. 63 cases. GECSA (Groupe d'Epidémiologie Clinique du SIDA en Aquitaine). Presse Medicale 21(1): 27-30

CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1. Proceedings. Biological Sciences 244(1310): 169-177

CD8 is involved in both class I- and class II-induced proliferation of a cytolytic T-cell clone with dual specificity for HLA-B27 and HLA-DR2 antigens. Human Immunology 24(4): 295-299

CD8 is required during positive selection of CD4-/CD8+ T cells. Journal of Experimental Medicine 171(2): 427-437

CD8 lymphocytes during Epstein Barr virus (EBV) infection: A CD29 positive population is expanded in acute infectious mononucleosis. Allergologia et Immunopathologia 19(2): 95-97

CD8 lymphocytosis and pseudotumoral splenomegaly in HIV infection. Lancet 340(8813): 207-208

CD8 suppressor cell activity and its effect on CD4 helper cell-dependent growth of SJL/J B-cell lymphomas. Cellular Immunology 122(2): 555-562

CD8 surface levels alter the fate of alpha/beta T cell receptor-expressing thymocytes in transgenic mice. Journal of Experimental Medicine 175(4): 1013-1025

CD8+ CD11+ suppressor cells in HIV-infected asymptomatic patients: effect on HIV-specific cytotoxicity. Viral Immunology 5(1): 15-25

CD8+ CD4- lymphocyte lines can harbor the AIDS virus in vitro. Journal of Immunology 143(10): 3412-3413

CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. Journal of Experimental Medicine 176(5): 1335-1341

CD8+ T cell response to Mls-1a determinants involves major histocompatibility complex class II molecules. Journal of Experimental Medicine 173(3): 779-782

CD8+ T cell subsets of cytotoxic T lymphocytes induced by Epstein-Barr virus infection in infectious mononucleosis. Tohoku Journal of Experimental Medicine 162(3): 213-224

CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proceedings of the National Academy of Sciences of the United States of America 85(2): 573-576

CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cellular Immunology 137(2): 420-428

CD8+ T cells in allergy. Allergy 47(1): 12-21

CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production. Cellular Immunology 114(2): 257-271

CD8+ T cells respond clonally to Mls-1a-encoded determinants. Journal of Experimental Medicine 171(4): 1381-1386

CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. Journal of Experimental Medicine 175(6): 1531-1538

CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals. Cellular Immunology 119(2): 470-475

CD8+ T lymphocyte subset in giant cell arteritis and related disorders. Journal of Rheumatology 17(2): 225-227

CD8+ T lymphocytes and progression to AIDS in HIV-infected men: some observations. Aids 5(2): 213-215

CD8+ T-cell clones deficient in the expression of the CD45 protein tyrosine phosphatase have impaired responses to T-cell receptor stimuli. Molecular and Cellular Biology 11(9): 4415-4422

CD8+ T-cell removal reduces survival of minor antigen mismatched islet allografts (CBA-->C3H) in mice treated with anti-CD4 monoclonal antibody. Transplantation Proceedings 24(5): 2297-2298

CD8+ T-cells from HIV-infected patients can either augment or abrogate HIV-specific lymphoproliferation. Clinical Immunology and Immunopathology 64(3): 254-260

CD8+ agranular lymphocyte proliferative disorder with T-cell receptor beta-chain gene rearrangement associated with thymoma and neutropenia. Japanese Journal of Clinical Hematology 30(10): 1865-1870

CD8+ alpha/beta or gamma/delta T cell receptor-bearing T cells from athymic nude mice are cytolytically active in vivo. Journal of Immunology 147(4): 1121-1126

CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. Journal of Clinical Investigation 87(4): 1462-1466

CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. Aids Research and Human Retroviruses 8(6): 1039-1050

CD8+ cell-dominant alveolitis in pulmonary sarcoidosis. Chest 95(1): 228-231

CD8+ cells sustain spontaneous IgG production in SLE. Immunology Today 10(2): 36-36

CD8+ cutaneous T-cell lymphoma. American Journal of Dermatopathology 13(6): 628-629

CD8+ cutaneous T-cell lymphoma with pagetoid epidermotropism and angiocentric and angiodestructive infiltration. Archives of Dermatology 126(6): 801-804

CD8+ cutaneous anaplastic large-cell lymphoma: report of two cases with immunophenotyping, T-cell-receptor gene rearrangement and electron microscopic studies. British Journal of Dermatology 126(4): 404-408

CD8+ high CD11b+ low T cells (T suppressor-effectors) in multiple sclerosis cerebrospinal fluid are increased during high dose corticosteroid treatment. Journal of Neuroimmunology 31(3): 221-228

CD8+ lymphocyte subset in polymyalgia rheumatica and arteritis temporalis. Inverse relationship between the acute hepatic phase reactants and the CD8+ T-cell subset. Clinical and Experimental Rheumatology 7(6): 627-630

CD8+ lymphocyte subsets in human follicular fluid. Fertility and Sterility 57(5): 1124-1125

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234(4783): 1563-1566

CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis. Arthritis and Rheumatism 33(8): 1216-1225

CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture. Cellular Immunology 128(2): 628-634

CD8+ lymphoma--skin lesions and observations of tumor cells by immunoelectron microscopy. Nihon Hifuka Gakkai Zasshi. Japanese Journal of Dermatology 99(4): 449-455

CD8+ suppressor cells inhibit staphylococcal protein A-induced gamma interferon production by CD4+ lymphocytes. Immunology Letters 27(1): 31-37

CD8+/DR+ T gamma cells inhibit the autologous mixed lymphocyte reaction. Clinical and Experimental Immunology 82(1): 174-180

CD8+/DR+/CD25--T-lymphocytes associated with marrow graft failure. Bone Marrow Transplantation 4(6): 647-652

CD8+CD11b+ peripheral blood T lymphocytes contain lymphokine-activated killer cell precursors. European Journal of Immunology 19(6): 1037-1044

CD8+T-cell lymphocytic alveolitis in sarcoidosis. 4 cases. Presse Medicale 20(13): 593-595

CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. Journal of Virology 61(10): 3102-3108

CD8/CD57 lymphocytosis in common variable immunodeficiency. Blood 77(6): 1400-1401

CD8B, the human equivalent of the mouse Ly-3 gene is localized on chromosome 2. Immunogenetics 27(1): 70-72

CD9 antigen on acute non-lymphoid leukemia cells: preferential expression by promyelocytic (M3) subtype. Leukemia Research 15(6): 457-461

CD9 antigen: will platelet physiology help to explain the function of a surface molecule during hemopoietic differentiation?. Nouvelle Revue Francaise D'hematologie 30(4): 201-202

CD9 is an unreliable antibody for bone marrow purging. Progress in Clinical and Biological Research 333: 185-189

CDA Component Dental Societies. Journal - California Dental Association 4(7): 34-35

CDA Council for Dental Materials and Devices. Status report: high copper amalgams. Dental Journal 43(9): 437-439

CDA Council for Dental Materials and Devices. Status report: periodontal dressings. Dental Journal 43(10): 501-502

CDA Council for Dental Materials and Devices. Status report: root canal sealing materials. Dental Journal 43(11): 538-539

CDA Task Force on Continuing Education. Dental Journal 42(2): 81-4, 93

CDA appoints new executive director (Hubert E. Drouin). Journal 45(5): 213-213

CDA directory. Journal - California Dental Association 3(7): 22-3, 29-94, 101-27

CDA gets "aggressive" with purchasers. Journal - California Dental Association 4(1): 52-56

CDA hosts HIV conference. Journal 57(6): 481-485

CDA introduces new ad campaign. Cda Journal 15(10): 93-93

CDA is alive and well and living in Ottawa. Dental Journal 44(6): 255-256

CDA members listed alphabetically. Journal - California Dental Association 5(7): 29-102

CDA members listed by city. Journal - California Dental Association 5(7): 108-138

CDA president urges dentists to unite: seek dialogue with governments. Dental Journal 44(10): 446, 448-446, 448

CDA says treating AIDS patients is opportunity to help those in need. Dental Office 10(9): 3, 5-3, 5

CDA successful in standard dental claim form negotiations. Journal 45(6): 271-271

CDA's Dental Plan Information Service. Helping the profession and the public understand prepaid dentistry. Journal - California Dental Association 6(4): 36-41

CDA's position clarified. Cda Journal 16(6): 36-37

CDA--1902-1992--90 years of leadership. Journal 58(10): 791-791

CDA--we need you real strong. Oral Health 66(1): 7-7

CDA-CDS, a conspiracy against the dentist?. Dental Dimensions 10(3): 6-9

CDAnet. Journal 58(7): 521-521

CDAs know the reasons why. Dental Assistant 46(2): 6-6

CDC (Center for Disease Control) outlines handwashing practices. Aorn Journal 22(4): 232, 234-232, 234

CDC 1991 recommendations for preventing HIV and HBV transmission. Today's Or Nurse 13(10): 37-41

CDC Diabetes Control Programs--overview of diabetes patient education. Diabetes Educator 10(4): 32-6, 57

CDC Effort focuses on injury control. Occupational Health & Safety 61(5): 12-13

CDC Guidelines for the Prevention and Control of Nosocomial Infections. Guidelines for prevention of surgical wound infections, 1985. American Journal of Infection Control 14(2): 71-82

CDC abandons plan for AIDS survey. Science 251(4991): 264-264

CDC advises on management of persons exposed to multiple-drug-resistant tuberculosis. Clinical Pharmacy 11(12): 991, 994, 999-991, 994, 999

CDC calls for AIDS testing for hospital patients. Ohio Medicine 87(11): 559-559

CDC clarifies recommendations for measles vaccination. Nurse Practitioner 16(11): 14-14

CDC clarifies "universal precautions". Immunizing HIV-positive children. American Journal of Nursing 88(10): 1322-1322

CDC collect neonatal herpes simplex virus data. Naacog Newsletter 13(4): 3-4

CDC conference held to define exposure-prone invasive procedures. Missouri Dental Journal 71(6): 22-23

CDC continues clinical hospital lab evaluations. Hospitals 53(5): 22-22

CDC criteria for anemia in children and childbearing-aged women. Mmwr. Morbidity and Mortality Weekly Report 38(22): 400-404

CDC definitions for nosocomial infections, 1988. American Journal of Infection Control 16(3): 128-140

CDC definitions for nosocomial infections, 1988. American Review of Respiratory Disease 139(4): 1058-1059

CDC directs states to set policy on HIV-infected health-care workers. Texas Medicine 88(9): 50-50

CDC drops plan. Minnesota Medicine 75(1): 44-44

CDC drops plan to restrict healthcare professionals with HIV from working. Occupational Health & Safety 61(1): 11-11

CDC estimates of disease transmission stir debate. Dentistry Today 10(4): 17-8, 82

CDC expands dental disease prevention role. JAMA 263(19): 2609-2609

CDC extends AIDS hotline for another 5 years. Public Health Reports 107(3): 364-365

CDC group HB-5 as a cause of genitourinary infections in adults. Journal of Clinical Microbiology 27(5): 801-805

CDC guide lists precautions against transmission of AIDS. American Nurse 19(9): 3, 33-3, 33

CDC guideline for handwashing and hospital environmental control, 1985. Today's Or Nurse 8(4): 26-37

CDC guideline for prevention of surgical wound infections, 1985. Supersedes guideline for prevention of surgical wound infections published in 1982. (Originally published in November 1985). Revised. Infection Control 7(3): 193-200

CDC guidelines for prevention of surgical wound infections, 1985. Today's Or Nurse 8(3): 33-40

CDC guidelines for the prevention and control of nosocomial infections. Guideline for handwashing and hospital environmental control, 1985. Supersedes guideline for hospital environmental control published in 1981. American Journal of Infection Control 14(3): 110-129

CDC guidelines on HIV or HBV-positive health care professionals performing exposure-prone invasive procedures. Law, Medicine & Health Care 19(1-2): 140-143

CDC has role in 40 worldwide health programs as World Health Organization collaborator. JAMA 263(19): 2570, 2574-2570, 2574

CDC health care courses offered. JAMA 263(19): 2617-2617

CDC holds forum on exposure prone procedures. Orthopedic Nursing 11(2): 86-87

CDC identifies listeriosis risks. Journal of the American Veterinary Medical Association 194(1): 34-34

CDC investigators explore new territory in aftermath of unrest in Los Angeles. JAMA 267(22): 3001-3002

CDC issues AIDS guidelines for health workers. American Nurse 18(1): 2, 22-2, 22

CDC issues draft patient testing guidelines. Journal of et Nursing 19(2): 34a-34a

CDC issues guidelines. Occupational Health & Safety 58(4): 12-12

CDC issues guidelines for multidrug-resistant tuberculosis. American Family Physician 46(4): 1303-1305

CDC issues guidelines for patient testing. American Nurse 23(10): 29-29

CDC issues guidelines for protection against viral hepatitis. Clinical Pharmacy 9(9): 670-670

CDC issues guidelines on HIV transmission by health-care workers. American Journal of Hospital Pharmacy 48(10): 2060, 2062-2060, 2062

CDC launches new AIDS-HIV public education campaign. Public Health Reports 105(5): 544-544

CDC launches new phase of AIDS education program. Public Health Reports 107(4): 487-488

CDC lists 'exposure-prone' procedures. Occupational Health & Safety 60(10): 16, 18-16, 18

CDC may not get much help from physicians. Rn 54(11): 12-12

CDC minority health office: 'social epidemiology'. JAMA 263(19): 2565-2566

CDC moves on chronic diseases. Journal of the National Cancer Institute 81(23): 1776-1777

CDC nears close of first half-century. JAMA 263(19): 2579-2580

CDC occupational HIV surveillance system. Infection Control and Hospital Epidemiology 13(12): 758-758

CDC open meeting to discuss invasive procedures under consideration for designation as exposure-prone and not exposure-prone. Journal of Dental Education 55(12): 810-813

CDC paints a picture of HIV infection in U.S. Science 239(4837): 253-253

CDC planners: resourcefulness essential. JAMA 263(19): 2616-2617

CDC plays cat-and-mouse with flu virus. JAMA 263(19): 2574, 2579-2574, 2579

CDC ponders new HIV guidelines. JAMA 264(9): 1079-1079

CDC recommendations for a community plan for the prevention and containment of suicide clusters. Mmwr Supplements 37(6): 1-12

CDC recommendations for preventing transmission of AIDS during invasive procedures. Texas Nursing 60(7): 14-14

CDC recommendations for preventing transmission of HIV and hepatitis B virus to patients during exposure-prone procedures. Oncology 5(10): 37-37

CDC recommendations on prevention of HIV transmission. Annals of Emergency Medicine 16(11): 1311-1311

CDC recommends a comprehensive strategy to eliminate HBV. American Family Physician 45(4): 1912-4, 1917

CDC recommends routine HIV testing at some hospitals. Minnesota Medicine 75(10): 48-49

CDC recommends voluntary HIV testing for health care workers. American Family Physician 44(2): 359-359

CDC releases HIV guidelines. American Nurse 23(8): 3-3

CDC releases guidelines: recommendations for preventing transmission of HIV and HBV to patients during exposure-prone invasive procedures. Pennsylvania Nurse 46(9): 7-8

CDC releases new reference criteria for anemia screening. American Family Physician 40(3): 303, 306, 308-303, 306, 308

CDC releases recommendations for prophylaxis against Pneumocystis carinii pneumonia. American Family Physician 46(1): 284-286

CDC releases recommendations on diagnosis and management of PID. American Family Physician 44(2): 673, 675-6

CDC releases updated guidelines for STD treatment. American Family Physician 40(6): 199-202

CDC reports AIDS deaths, cases. Journal of the American Dental Association 122(3): 24, 26-24, 26

CDC reports caution obstetric personnel, patients about AIDS virus. Naacog Newsletter 13(6): 1, 5-1, 6

CDC reports increases in infection control program. Aorn Journal 28(1): 168-169

CDC revising treatment guidelines for HIV-infected health care workers. Journal of the American Dental Association 122(2): 20-20

CDC seeks a sex policy. Science 256(5054): 167-167

CDC should admit possibility of Lyme. Missouri Medicine 89(10): 713-713

CDC studies HIV transmission risk during invasive procedures. Journal of the Oklahoma State Medical Association 84(4): 184-187

CDC study: no evidence for teratogenicity of Bendectin. JAMA 242(23): 2518-2518

CDC summarizes final regulations for implementing CLIA. American Family Physician 45(6): 2803-2805

CDC surrenders to health groups on AIDS strategy. American Journal of Nursing 92(2): 84-84

CDC to amend AIDS definition. Ohio Medicine 87(10): 493-493

CDC to list exposure-prone procedures for HIV-infected physicians. Texas Medicine 87(11): 20-20

CDC updates guidelines. Rdh 11(10): 24, 26-24, 26

CDC updates guidelines for influenza control. Clinical Pharmacy 9(11): 823, 827, 830-2

CDC updates recommendations on treatment of sexually transmitted diseases. Clinical Pharmacy 9(1): 3, 6-3,11

CDC updates recommendations to prevent HIV and HBV transmission to patients. American Family Physician 44(4): 1468, 1471-1468, 1471

CDC urges AIDS testing for all hospital patients. American Journal of Nursing 91(11): 81-81

CDC veteran upholds the bottom line: prevention. JAMA 263(19): 2614, 2616-2614, 2616

CDC warns researchers. Occupational Health & Safety 58(3): 17-17

CDC's AIDS effort marred. Occupational Health & Safety 58(2): 12-12

CDC's HIV Public Information and Education Programs. Public Health Reports 106(6): 601-732

CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing. Public Health Reports 105(2): 167-171

CDC's approach to firearm injuries. JAMA 262(3): 348-349

CDC's definition of AIDS. New England Journal of Medicine 315(12): 761-761

CDC's hot line: 'America responds to AIDS'. JAMA 263(19): 2587-2588

CDC, statistics center weather 'marriage'. JAMA 263(19): 2580-2580

CDC17: an essential gene that prevents telomere elongation in yeast. Cell 42(1): 249-257

CDC25-dependent induction of inositol 1,4,5-trisphosphate and diacylglycerol in Saccharomyces cerevisiae by nitrogen. Febs Letters 307(3): 249-252

CDC25: a component of the RAS-adenylate cyclase pathway in Saccharomyces cerevisiae. Science 235(4793): 1218-1221

CDC33 encodes mRNA cap-binding protein eIF-4E of Saccharomyces cerevisiae. Molecular and Cellular Biology 8(8): 3556-3559

CDC42 and CDC43, two additional genes involved in budding and the establishment of cell polarity in the yeast Saccharomyces cerevisiae. Journal of Cell Biology 111(1): 131-142

CDC7 protein kinase activity is required for mitosis and meiosis in Saccharomyces cerevisiae. Molecular & General Genetics 227(3): 452-457

CDC7-dependent protein kinase activity in yeast replicative-complex preparations. Proceedings of the National Academy of Sciences of the United States of America 85(7): 2101-2105

CDC: let states decide. Minnesota Medicine 75(8): 43-44

CDC: the nation's prevention agency. Mmwr. Morbidity and Mortality Weekly Report 41(44): 833-833

CDDP and 5-FU after prior VBM or VBM after prior CDDP and 5-FU in the management of recurrent squamous cell carcinoma of the head and neck?. European Journal of Cancer & Clinical Oncology 22(12): 1539-1540

CDDP concentration of bladder tumors--comparison between intraarterial infusion and intravenous infusion. Nihon Gan Chiryo Gakkai Shi 23(4): 859-866

CDDP-ACR treatment in patients with recurrent ovarian cancer with prior chemotherapy containing CDDP--a preliminary study of a 14-day continuous infusion of CDDP with ACR. Nihon Sanka Fujinka Gakkai Zasshi 41(10): 1565-1570

CDDP-induced tumor cell perturbation by flow cytometric study. Nihon Gan Chiryo Gakkai Shi 22(7): 1399-1407

CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 18(11): 2047-2051

CDEM survey results--the verdict is in. Journal of the Kansas Dental Association 77(4): 24-6, 28-30, 32

CDEs in 1988: a two-year progress report. Diabetes Educator 14(6): 483-486

CDEs in 1990: a report of years 3 and 4 (1988 and 1989) of the certification process. Diabetes Educator 17(1): 20-22

CDF/LIF selectively increases c-fos and jun-B transcripts in sympathetic neurons. Neuroreport 2(4): 173-176

CDH studies rural injury rates and compares Colorado death rates to national rates. Colorado Medicine 86(15): 283-283

CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. Proceedings of the National Academy of Sciences of the United States of America 89(7): 2907-2911

CDMIE update on posterior composites. Dental Update 14(3): 97-98

CDO turns racecourse doctor. British Dental Journal 166(3): 97-97

CDP choline and cerebrovascular insufficiency in the elderly. Clinical study of 40 patients undergoing prolonged treatment. Minerva Cardioangiologica 33(3): 145-148

CDP choline and experimental cerebrovascular disorder. Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de L'agression 27(5): 413-416

CDP choline and glucose metabolism. Study of clinical pharmacology. Minerva Dietologica E Gastroenterologica 31(1): 15-20

CDP-choline for the treatment of tardive dyskinesia: a small negative series. Comprehensive Psychiatry 30(1): 1-4

CDP-choline improves the postoperative rehabilitation of patients with cerebral risk. Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de L'agression 31(7): 457-463

CDP-choline in the treatment of cranio-encephalic traumata. Journal of the Neurological Sciences 103 Suppl: S43-S47

CDP-choline: 1,2-diacylglycerol cholinephosphotransferase from rat liver microsomes. II. Photoaffinity labeling by radioactive CDP-choline analogs. Biochimica et Biophysica Acta 1124(1): 36-44

CDP-glycerol:poly(glycerophosphate) glycerophosphotransferase, which is involved in the synthesis of the major wall teichoic acid in Bacillus subtilis 168, is encoded by tagF (rodC). Journal of Bacteriology 174(2): 646-649

CDP: a major breakthrough!. Pediatrics 58(6): 783-787

CDRI-85/287, a novel antiestrogen and antiimplantation agent: biological profile and interaction with the estrogen receptors in immature rat uterus. Contraception 45(1): 81-92

CDS Emergency Dental Service: Success depends on volunteers. Cds Review 68(8): 16-17

CDS Executive Vice President to assume new role. Dental Dimensions 11(2): 19-19

CDS goes after AIDS data. Cds Review 81(4): 15-15

CDS review wins again!. Cds Review 69(4): 15-15

CDS: epidemiology and treatment of client groups 'unwanted' by other services. Community Dental Health 4(2): 195-196

CDSC report. Outbreak of poliomyelitis in Finland. British Medical Journal 291(6487): 41-42

CDSC: from Cox to Acheson. Community Medicine 11(3): 187-199

CDT today: a new year, a new program. Trends & Techniques in the Contemporary Dental Laboratory 6(10): 31-33

CDT today: can we schedule an examination here?. Trends & Techniques in the Contemporary Dental Laboratory 2(2): 44-46

CDT today: candidate rights to appeal grades. Trends & Techniques in the Contemporary Dental Laboratory 9(3): 61-62

CDT today: certification and legislation. Trends & Techniques in the Contemporary Dental Laboratory 7(3): 53-54

CDT today: guidelines for the complete denture specialty practical examination. Trends & Techniques in the Contemporary Dental Laboratory 6(6): 45-46

CDT today: guidelines for the orthodontic specialty practical examination. Trends & Techniques in the Contemporary Dental Laboratory 6(9): 49-50

CDT today: new standards for practical examinations -- ceramics. Trends & Techniques in the Contemporary Dental Laboratory 9(9): 49-50

CDT today: new standards for practical examinations -- crown & bridge. Trends & Techniques in the Contemporary Dental Laboratory 9(8): 53-54

CDT today: the ceramic specialty examination. Trends & Techniques in the Contemporary Dental Laboratory 3(3): 36-37

CDT today: the orthodontic specialty examination. Trends & Techniques in the Contemporary Dental Laboratory 2(1): 53-53

CDT today: the successful grade appeal. Trends & Techniques in the Contemporary Dental Laboratory 9(4): 57-58

CDT today: what are we doing?. Trends & Techniques in the Contemporary Dental Laboratory 6(7): 31-32

CDT today: what is the comprehensive examination?. Trends & Techniques in the Contemporary Dental Laboratory 2(3): 44-44

CDT today: who does what?. Trends & Techniques in the Contemporary Dental Laboratory 2(7): 38-40

CDT today: who writes the tests?. Trends & Techniques in the Contemporary Dental Laboratory 2(4): 37-9, 41

CDU: concerned with rehabilitation of the chemically dependent person. Journal of the Mississippi State Medical Association 20(5): 100-101

CDw17: a neutrophil glycolipid antigen regulated by activation. Journal of Immunology 142(8): 2784-2790

CDw40 and BLCa-specific monoclonal antibodies detect two distinct molecules which transmit progression signals to human B lymphocytes. European Journal of Immunology 18(3): 451-457

CE Dukes. British Medical Journal 1(6060): 588-588

CE and the rural nurse: assertiveness counts. Ce Focus 1(1): 9-9

CE evaluation seeks to measure impact on practice. Aorn Journal 30(6): 1100, 1102, 1104-1100, 1102, 1104

CE feature. Part 1. Neurophysiology of pain. Orthopedic Nursing 9(4): 21-25

CE feature. Part 2. Nontechnologic strategies for coping with chronic low back pain. Orthopedic Nursing 9(4): 26-34

CE inhibition and natriuresis with ramipril in conscious SHR: different modes of action of loop and thiazide diuretics. Journal of Cardiovascular Pharmacology 10 Suppl 7: S141-S144

CE philosophy, objectives for members' review. Aorn Journal 24(4): 625-628

CE: current contradictions in inservice. Nursing Administration Quarterly 2(2): 65-71

CE: out-dated notions can't up-date nurses. Nursing Management 16(5): 35-38

CE: voluntary or mandatory?. Dental Economics - Oral Hygiene 77(5): 37-40

CEA (carcinoembryonic antigen). Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl: 2146-2147

CEA (carcinoembryonic antigen): its value as an early indicator of recurrence of neoplastic disease in carcinoma of the colon and rectum. Minerva Chirurgica 44(11): 1597-1599

CEA MARIA serum levels in gastrointestinal pathologies. Bulletin du Cancer 75(2): 225-227

CEA and ABO antigens as early signs of malignancy in urotheliomas of the upper urinary tract. Archivos Espanoles de Urologia 39(8): 529-533

CEA and CA 15-3 in primary and recurrent breast cancer. World Journal of Surgery 14(5): 562-5; Discussion 565-6

CEA and CA 19-9 in benign pulmonary or mediastinal cystic lesions. Journal of Surgical Oncology 41(2): 103-108

CEA and CA 19.9 in gastric juice and serum: an aid in the diagnosis of gastric carcinoma?. European Journal of Surgical Oncology 15(3): 253-257

CEA and CA 19.9: an evaluation by new statistical technics on a group of elderly patients. Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 23(1): 32-42

CEA and CA19-9 in BALF from patients with idiopathic interstitial pneumonia. Nihon Kyobu Shikkan Gakkai Zasshi 27(8): 887-893

CEA and NCA levels in peripheral and tumour venous blood of patients with gastric and colonic carcinomas estimated by RIA and EIA methods. European Journal of Surgical Oncology 17(1): 59-64

CEA and TPA in bladder carcinoma. Minerva Medica 77(13): 505-506

CEA and TPA in cancer of the breast. Findings and criteria of use. Revista Espanola de Oncologia 32(2): 265-280

CEA and breast neoplasms: application of a personal method for determination of CEA in the clinical study of 242 patients. Bulletin du Cancer 66(3): 259-267

CEA and cancer of the cervix uteri. Bulletin du Cancer 63(4): 514-518

CEA and carbohydrate antigens in normal and neoplastic colon mucosa. An immunohistochemical study. Acta Pathologica, Microbiologica, et Immunologica Scandinavica. Section A, Pathology 95(4): 177-183

CEA and ferritin in chronic pancreatic disease: a comparative evaluation. Hepato-Gastroenterology 32(3): 146-148

CEA and ovarian cancer: do we now know its clinical value?. Tumour Biology 7(5-6): 331-331

CEA and second-look surgery. Seminars in Surgical Oncology 7(3): 127-180

CEA and the liver. Gastroenterology 73(4 Pt 1): 862-863

CEA and therapeutic strategy especially in breast cancers. Bulletin du Cancer 63(4): 587-593

CEA as a cell adhesion molecule. Gastroenterology 99(1): 277-278

CEA as a monitor of gastrointestinal malignancy. Cancer 35(3): 830-836

CEA as a tumor marker on the cell surface and in the exudate. Comparison in thoracoscopy examined pleural effusions. Pneumologie 44 Suppl 1: 529-530

CEA as an adjunct in the diagnosis and prognosis of colorectal carcinoma. Review of Surgery 32(3): 214-217

CEA as an early indicator for second-look procedure in colorectal carcinoma. Review of Surgery 34(1): 1-4

CEA assay in the follow-up of patients with extra-gastrointestinal malignancies. Bulletin du Cancer 63(4): 495-504

CEA blood level in patients with Crohn's disease with reference to localization, duration and severity of the disease. Fortschritte der Medizin 95(47-48): 2795-2798

CEA content of colonic polyps. American Journal of Clinical Pathology 85(2): 255-255

CEA content of the gastric juice in comparison with histological and macroscopic findings in the gastric mucosa. Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 36(3-4): 141-142

CEA content of tissue and body fluids of patients with gastric cancer: relation of tumor tissue, gastric juice and serum levels. Zhonghua Nei Ke Za Zhi 24(11): 662-5, 701-2

CEA demonstration in malignant stem cells of sarcomas and carcinomas. Deutsche Zeitschrift für Mund-, Kiefer- und Gesichts-Chirurgie 12(2): 138-140

CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors. Zentralblatt für Gynakologie 110(16): 1006-1012

CEA determination in the follow-up of colorectal cancers. Zentralblatt für Chirurgie 112(15): 968-974

CEA determination in tobacco smokers as a prophylactic factor. Polski Przeglad Radiologii i Medycyny Nuklearnej 43(5): 313-315

CEA determination in urogenital tract neoplasms. Das Medizinische Laboratorium 29(9): 193-198

CEA directed second-look surgery for colon and rectal cancer. Annales Chirurgiae et Gynaecologiae 78(1): 32-37

CEA elevation 16 months after the detection of liver metastases in colonic carcinoma. Deutsche Medizinische Wochenschrift 110(14): 562-562

CEA family syndrome. Abnormal carcinoembryonic antigen (CEA) levels in asymptomatic retinoblastoma family members. Cancer 37(3): 1397-1402

CEA immunoperoxidase staining. An applied research tool for a community hospital laboratory. Indiana Medicine 78(7): 592-594

CEA immunoreactivity in odontogenic tumors and keratocysts. Oral Surgery, Oral Medicine, and Oral Pathology 66(5): 576-580

CEA in colonic adenocarcinomas and precancerous lesions. An immunohistochemical study with a novel monoclonal antibody. Apmis 97(12): 1073-1080

CEA in diagnosis of jaundice. New England Journal of Medicine 296(23): 1356-1357

CEA in patients with neoplasm metastases. Die Medizinische Welt 29(20): 828-830

CEA levels at recurrence and metastases; importance for detecting secondary disease. Scandinavian Journal of Gastroenterology 10(8): 869-874

CEA levels in fluids bathing gastrointestinal tumors. Gastroenterology 70(4): 513-515

CEA levels in gastric juice in precancerous conditions and cancer. International Journal of Biological Markers 2(2): 101-104

CEA levels in head and neck cancer. Cancer 37(5): 2204-2211

CEA levels in patients with carcinoma of the esophagus. Cancer 42(3 Suppl): 1492-1497

CEA levels in patients with colorectal polyps. Cancer 36(6): 1996-2003

CEA levels in peritoneal washings from gastric cancer patients as a prognostic guide. Cancer Letters 47(1-2): 79-81

CEA levels of draining venous blood and draining-peripheral CEA gradient in colorectal cancer patients: correlation with postoperative survival. Nihon Geka Gakkai Zasshi 91(5): 575-580

CEA plasma levels in patients with intracranial tumours. Neurochirurgia 30(1): 5-7

CEA serum level in patients with liver diseases. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 1201-1204

CEA studies in endometrial cancer. Zentralblatt für Gynakologie 111(8): 524-529

CEA studies in squamous cell carcinomas of the head and neck. Hno 34(8): 334-342

CEA test in domestic animals. Schweizer Archiv für Tierheilkunde 133(7): 311-313

CEA tissue staining in colorectal cancer patients. A way to improve the usefulness of serial serum CEA evaluation. Cancer 55(11): 2624-2629

CEA titer in esophageal carcinoma. Acta Chirurgica Iugoslavica 25 Suppl 1: 47-49

CEA, GICA, TPA, fibrinopeptide-A, gamma-GT and gastric cancer. A contribution to the rationalization of a combined assay. Recenti Progressi in Medicina 82(10): 517-519

CEA, SP1 and HCG in serum and tissue homogenates of patients with gynecologic neoplasms. Archives of Gynecology 228(1-4): 664-665

CEA, TPA and APP as a guide in the surgical therapy and follow-up of pancreatic cancer. Minerva Medica 77(13): 489-493

CEA, tumour differentiation and DNA ploidy pattern. Scandinavian Journal of Gastroenterology. Supplement 149: 166-178

CEA- monoclonal antibody as a marker of myeloid tissue in bone marrow biopsies. International Journal of Biological Markers 2(3): 209-210

CEA--methods of its determination and clinical evaluation (1). Nihon Rinsho. Japanese Journal of Clinical Medicine 34(6): 1274-1279

CEA--methods of its determination and their clinical evaluation (2). Nihon Rinsho. Japanese Journal of Clinical Medicine 34(7): 1486-1491

CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classes. Cancer Immunology, ImmunoTherapy 26(2): 180-184

CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma. Annals of Surgery 202(3): 310-317

CEA-related antigens: molecular biology and clinical significance. Critical Reviews in Oncology/Hematology 2(4): 355-399

CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies. Anticancer Research 6(1): 97-104

CEA: a guide for the clinician. Nebraska Medical Journal 64(8): 249-250

CEA: a monitor of therapy for breast and colon cancer. American Family Physician 17(4): 173-176

CEA: an exam to be used in diagnostic laboratories or still only for research purposes? Current status. Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 13(3): 331-349

CEAP procedure revised and "user friendly". Mna Accent 64(5): 8-9

CEB 13 detects a VNTR locus (Het: 93%) on chromosome 7q. Human Molecular Genetics 1(1): 64-64

CEB 15 detects a VNTR locus (Het: 92%) on chromosome 1p. Human Molecular Genetics 1(1): 63-63

CEB 29 detects a VNTR locus (Het: 80%) on chromosome XY. Human Molecular Genetics 1(1): 63-63

CEB speakers urge employers to become involved in hospital cost control programs. Employee Benefit Plan Review 31(6): 8-9

CEDI--a computer programme for differential diagnostics of organic brain lesions. Methods of Information in Medicine 14(1): 19-25

CEDIA in vitro diagnostics with a novel homogeneous immunoassay technique. Current status and future prospects. Journal of Immunological Methods 150(1-2): 99-102

CEDIA, a new homogeneous immunoassay system. Clinical Chemistry 32(9): 1637-1641

CEDIA--homogeneous immunoassays for the 1990s and beyond. Wiener Klinische Wochenschrift. Supplementum 191: 5-11

CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatment. Schizophrenia Research 6(1): 15-23

CEFOBID in the treatment of respiratory tract infection (preliminary report). Pneumonologia Polska 57(7-9): 403-408

CEIR forum on radionuclides and external irradiation: implications for the embryo and fetus. Meeting report (with extended abstracts). London, 9 November 1990. International Journal of Radiation Biology 60(3): 543-569

CELISA for rapid screening of monoclonal islet cell surface antibodies using living rat insulinoma cells as target. Diabetes Research 16(1): 41-45

CELLBASE: a database management system for the control of cell line storage. Computer Applications in the Biosciences 4(3): 408-408

CEM and AI. Veterinary Record 102(15): 349-349

CEM contagious equine metritis: a transmissible disease with international implications. Modern Veterinary Practice 59(11): 819-822

CEM sampling. Veterinary Record 104(25): 585-585

CENETROP: a joint Belgian-Bolivian medical development project in Santa Cruz, Bolivia. Annales de la Societe Belge de Medecine Tropicale 59(3): 325-327

CENP-B is a highly conserved mammalian centromere protein with homology to the helix-loop-helix family of proteins. Chromosoma 100(6): 360-370

CENP-B: a major human centromere protein located beneath the kinetochore. Journal of Cell Biology 110(5): 1475-1488

CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate. Cell 70(1): 115-125

CENP-E, a novel human centromere-associated protein required for progression from metaphase to anaphase. Embo Journal 10(5): 1245-1254

CEO advice on consultants: buy wisely; use well. Hospitals 63(3): 52, 54-52, 54

CEO builds employee morale to improve finances. Hospitals 62(11): 110-110

CEO burnout: shift priorities to manage stress. Hospitals 64(9): 67-67

CEO closes a hospital, yet retains support of physicians and patients. Hospitals 64(22): 24-26

CEO commitment key to organizational change. Hospitals 64(2): 76-76

CEO firings: the medical staff's key role. Hospitals 64(4): 70-70

CEO firings: warning signs of unhappy boards. Hospitals 65(19): 56-56

CEO gives local corporations a new guide to measure quality. Hospitals 64(22): 29-31

CEO keeps high public profile. Hospitals 64(12): 54-54

CEO looks to vendors for savings. Hospitals 64(1): 60-61

CEO pay. Public scrutiny and pay for performance are the new ground rules. Hospitals 66(12): 22, 24-22, 24

CEO recognizes importance of content workforce. Hospitals 63(2): 56-56

CEO represents hospitals on technology council. Hospitals 63(6): 72-72

CEO role grows in clinical supply purchasing. Hospitals 62(9): 70-71

CEO shares information with his employees. Hospitals 63(7): 54-54

CEO succession and its relationship to CNO tenure. Journal of Nursing Administration 17(7-8): 27-30

CEO support key to success of health care recycling. Hospitals 65(14): 60-60

CEO ups admissions by making hospital physician-friendly. Hospitals 64(20): 72, 74-72, 74

CEO uses video to recruit physicians to northeastern Kentucky. Hospitals 62(11): 44-45

CEO walkabouts get firsthand look at employee problems. Hospitals 64(9): 50-51

CEO's service orientation earns top Texas business award. Hospitals 64(17): 73-73

CEO's vision: to make health care satisfying again. Hospitals 64(5): 46-46

CEO-board relations: an update. Hospitals 63(7): 38-42

CEO: an agent of planned change. Hospital Progress 59(2): 54-7, 75

CEO: physician input vital to quality improvement. Hospitals 63(14): 22-22

CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report. Tumori 76(6): 533-536

CEOs adapt style to cope with outpatient growth. Hospitals 65(15): 60-60

CEOs and the media strive for balance. Hospitals 62(5): 42-44

CEOs as risk takers--from vision to reality. Hospitals 64(22): 24-34

CEOs begin to share control of IS purchases. Hospitals 65(2): 48-48

CEOs call shots on communications purchasing. Hospitals 62(11): 115-115

CEOs can make it easier to drive a hard bargain. Hospitals 63(11): 58, 60-58, 60

CEOs cautioned to watch Stark's referral bill. Hospitals 63(2): 60-60

CEOs cite job satisfaction; experts see risks. Hospitals 65(12): 62-62

CEOs cite ways to improve medical staff relations. Hospitals 61(6): 114, 116-114, 116

CEOs confront service cuts. Hospitals 63(19): 38-43

CEOs confuse roles of physician trustees. Hospitals 66(18): 54-54

CEOs expect slow, steady managed care growth. Hospitals 65(21): 16-16

CEOs face mounting stress from finances, regs. Hospitals 65(18): 68-68

CEOs forecast slight gain in executive demand. Hospitals 61(23): 71, 74-71, 74

CEOs help physicians cope with growing professional stress. Hospitals 66(16): 40, 42-3

CEOs hold jobs longer than other top managers. Modern Healthcare 9(6): 57-57

CEOs hone in on major purchasing decisions. Hospitals 60(7): 82, 84-82, 84

CEOs in jeopardy: reading the warning signs. Hospitals 63(12): 90-90

CEOs link IS visions to hospital strategic plans. Hospitals 66(23): 42, 44, 46-42, 44, 46

CEOs make the most of trustees' business acumen. Hospitals 64(11): 28-33

CEOs must bolster hospital-physician ties. Hospitals 60(15): 80-80

CEOs neglect materials cost cutting: survey. Hospitals 61(2): 100, 102-3

CEOs nursed bottom lines to promote mission. Hospitals 62(24): 76-76

CEOs outline changes in collaboration. Hospitals 65(17): 16-16

CEOs plan resource shift for 1986. Hospitals 59(24): 69-70, 72

CEOs plan to expand home health, outpatient services. Hospitals 59(1): 74-77

CEOs play key advocacy role in health policy issues. Hospitals 64(12): 26-32

CEOs say hospitals must learn from each other for TQM success. Hospitals 66(12): 42-4, 46-8, 50

CEOs say patient deposits improve cash flow. Hospitals 65(4): 48-48

CEOs see major payment changes within two years. Hospitals 61(4): 32-32

CEOs see money crunch, retrenchment ahead. Hospitals 60(19): 73-73

CEOs should prepare carefully for interviews. Hospitals 64(1): 74-74

CEOs should spend more time with boards. Hospitals 63(14): 72-72

CEOs skeptical of Bush's health policy stance. Hospitals 64(9): 58-58

CEOs split over Oregon Medicaid reform. Hospitals 64(2): 75-75

CEOs support tough physician screening criteria. Hospitals 64(11): 66-66

CEOs take a new look at the CIO function. Hospitals 64(11): 64-64

CEOs tied down by HMO/PPA red tape. Hospitals 61(3): 44-48

CEOs want more board involvement in planning. Hospitals 64(11): 16-16

CEOs weigh factors in selecting new technologies. Hospitals 66(9): 18-18

CEOs who negotiate get top retirement plans. Hospitals 64(20): 88-88

CEOs: Gulf crisis hits hospitals' bottom line. Hospitals 64(23): 46-46

CEOs: civic leadership boosts hospitals' image. Hospitals 66(1): 64-64

CEOs: decline in stays for births will bottom out. Hospitals 65(6): 50-50

CEOs: evolving JCAHO surveys merit high marks. Hospitals 66(9): 84-84

CEOs: funding key to ending public health crisis. Hospitals 64(17): 92-92

CEOs: keep capital fold-in out of budget politics. Hospitals 64(15): 25-25

CEOs: learning to cope with high stress levels. Hospitals 66(10): 68-68

CEOs: managing stress key to success, sanity. Hospitals 65(9): 48-48

CEOs: mortality data no help to consumers. Hospitals 64(19): 61-61

CEOs: no regrets about their career choice. Hospitals 66(11): 66-66

CEOs: planning next career move no easy task. Hospitals 66(21): 70-70

CEOs: politics hurts long-term medical research. Hospitals 64(16): 22-22

CEOs: survival tips for the tough times ahead. Hospitals 65(22): 56-56

CEOs: tax-exempt debate bypasses larger issues. Hospitals 65(11): 55-55

CEOs: there's no simple cure for billing and pricing woes. Hospitals 66(12): 26-33

CEOs: well-informed reporters can be powerful hospital allies. Hospitals 65(21): 38, 40-2

CEPH maps. Current Opinion in Genetics & Development 2(3): 393-399

CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma. Blood 76(7): 1293-1298

CEPRIME (Continuing Education and Peer Review in Internal Medicine): linking quality assurance with continuing medical education. Australian Clinical Review 6(23): 183-189

CEREC CAD/CAM inlays: aesthetics and durability in a single appointment. Dentistry Today 9(8): 20, 22-20, 22

CEREC(R) CAD-CAM ceramic restorations. A case report after 5 years in place. Acta Stomatologica Croatica 25(1): 3-10

CERVISCAN: an image analysis system for experiments in automatic cervical smear prescreening. Computers and Biomedical Research, An International Journal 9(2): 93-107

CESAR: presentation of an original respirator. Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de L'agression 32(4): 236-245

CETA: some case studies. Social Policy 6(3): 44-48

CEU program--digitalis. Ad Nurse 3(6): 14-17

CEU your jewish patient is dying.... Ad Nurse 4(1): 12-17

CEUSPEC--a computerized system for fetal home telemetry. International Journal of Bio-Medical Computing 18(2): 145-153

CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist. British Journal of Pharmacology 56(3): 371p-371p

CF DNA-diagnosis and gene mutation analysis: data from East Germany. Pathologie-Biologie 39(6): 585-586

CF and emphysema. Chest 96(3): 705-706

CF screening delayed for awhile, perhaps forever. Science 247(4948): 1296-1297

CF. Not just a pediatric problem anymore. Rn 53(9): 60-65

CF0, the proton channel of chloroplast ATP synthase. After removal of CF1 it appears in two forms with highly different proton conductance. European Journal of Biochemistry 179(2): 459-467

CF1-dependent restoration of energy-linked reactions reconstituted with a hydrophobic protein from spinach chloroplasts. Biochemical and Biophysical Research Communications 77(1): 168-174

CFA/V is not a new fimbrial type of human colonization factor antigen. Journal of Infectious Diseases 158(3): 663-664

CFC gases in medicinal sprays. Ugeskrift for Laeger 151(12): 753-755

CFC pollution: vets at fault?. Veterinary Record 124(1): 22-22

CFC syndrome in mother and daughter: a syndrome distinct from Noonan syndrome. Annales de Dermatologie et de Venereologie 118(11): 778-780

CFDE--a helping hand. Dental Journal 42(9): 444-444

CFDE--a reflection of the profession's interest in the future. Dental Journal 41(9): 495, 497-495, 497

CFDE--the second million. Dental Journal 44(9): 390-390

CFM specialist: the key to a better hospital-primary care relationship?. Atencion Primaria 6(10): 753-753

CFMC: professional evaluation process--hospital care (Colorado Foundation for Medical Care). Colorado Medicine 84(8): 150-151

CFOs identify ways hospitals can build financial strength. Hospitals 66(17): 57-59

CFOs see future differently: study. Hospitals 60(20): 54-54

CFOs see major shifts coming in their hospital roles ... while others have completed their transitions. Hospitals 60(23): 50, 52-50, 52

CFOs see physician relations as key to financial performance. Hospitals 64(16): 38-42

CFOs share their asset-management strategies. Hospitals 62(9): 30, 32-3

CFOs' focus the same despite changing times. Hospitals 62(2): 22-24

CFOs' use of money managers on the rise. Hospitals 61(18): 32-32

CFOs: cost-shift pressures will spur health care policy reform. Hospitals 65(16): 38, 40, 42-3

CFOs: doing more, paid more, aspiring less?. Hospitals 61(19): 32, 34-32, 34

CFPC urged to take direct role in health care planning. Canadian Medical Association Journal 133(1): 52-52

CFPC, OMA programs help family doctors cope with AIDS. Cmaj 140(8): 943-944

CFTR illegitimate transcription in lymphoid cells: quantification and applications to the investigation of pathological transcripts. Human Genetics 88(5): 508-512

CFTR: development of high- affinity antibodies and localization in sweat gland. Biochemical and Biophysical Research Communications 181(1): 36-43

CFU-C abnormalities and cytochemical defects in bone marrow of adult patients during remission of acute leukemia. Leukemia Research 9(5): 613-616

CFU-C and colony stimulating activity in human aplastic anemia. Haematology and Blood Transfusion 24: 87-95

CFU-C populations in blood and bone marrow of dogs after lethal irradiation and allogeneic transfusion with cryopreserved blood mononuclear cells. Scandinavian Journal of Haematology 21(2): 115-130

CFU-F circulating in cord blood. Blut 54(6): 351-359

CFU-F from dog marrow: a colony assay and its significance. Blut 50(2): 81-87

CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy. Bone Marrow Transplantation 2(2): 165-173

CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow. Blood 70(1): 271-275

CFU-GM inhibitors in neutropenia. Clinical and Laboratory Haematology 11(1): 31-45

CFU-GM of bone marrow in paroxysmal nocturnal hemoglobinuria. Zhonghua Nei Ke Za Zhi 25(12): 712-4, 774

CFU-GM: CFU-mix ratio in the peripheral blood and bone marrow and its importance in autologous transplantation of circulating stem cells. British Journal of Haematology 64(3): 628-629

CFU-M-derived human megakaryocytes synthesize glycoproteins IIb and IIIa. Blood 67(3): 682-688

CFU-S and haematopoietic microenvironment in mice after fractionated irradiation. A study on spleen colonies. General Physiology and Biophysics 11(2): 169-179

CFU-S content and cycling rate in several strains of mice. Experimental Hematology 15(7): 759-764

CFU-S in individual erythroid colonies derived in vitro from adult mouse marrow. Nature 279(5715): 718-720

CFU-S in syngeneic extramedullary bone marrow transplants. Doklady Akademii Nauk SSSR 249(3): 723-725

CFU-c changes in hemopoietic dysplasia and their significance. Japanese Journal of Clinical Hematology 20(10): 1269-1272

CFU-gm assay, cytochemical and electron microscopic studies in agar in patients with preleukemic syndrome and aplastic anemia. International Journal of Cell Cloning 3(6): 367-387

CFU-gm colony formation of peripheral blood and bone marrow in adult acute leukemia at presentation, during remission, and at relapse. International Journal of Cell Cloning 3(4): 199-213

CFU-mix are no better than CFU-GM in predicting hemopoietic reconstitutive capacity of peripheral blood stem cells collected in the very early remission phase of acute nonlymphoblastic leukemia. Experimental Hematology 15(4): 351-354

CFU-rAM, the origin of lung macrophages, and the macrophage lineage. American Journal of Physiology 263(3 Pt 1): L299-L307

CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series. Human Genetics 87(2): 177-182

CG doublet difficulties in vertebrate DNA. Nature 313(6002): 437-438

CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. Journal of Neuroscience Research 31(1): 193-204

CGA-7 and HHF, two monoclonal antibodies that recognize muscle actin and react with adherent cells in human long-term bone marrow cultures. Blood 66(5): 1138-1142

CGD associated with cytochrome B deficiency: granulocyte function tests 25 months after bone marrow transplantation. Acta Paediatrica Hungarica 29(1-2): 229-232

CGP 11.952: an experimental benzodiazepine derivative. Effects on cognitive functioning in patients with epilepsy. Progress in Neuro-Psychopharmacology & Biological Psychiatry 11(6): 673-682

CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study. Pharmacopsychiatry 21(4): 203-207

CGP 20712 A: a useful tool for quantitating beta 1- and beta 2-adrenoceptors. European Journal of Pharmacology 130(1-2): 137-139

CGP 22979A, a renal vasodilator with natriuretic properties. Journal of Pharmacology and Experimental Therapeutics 232(3): 838-844

CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure. Naunyn-Schmiedeberg's Archives of Pharmacology 342(3): 305-311

CGP 31358 binds to a site on the NMDA receptor that is coupled to both the transmitter recognition site and the channel domain. Neuroscience Letters 107(1-3): 184-188

CGP 35348, a new GABAB antagonist, prevents antinociception and muscle-relaxant effect induced by baclofen. British Journal of Pharmacology 103(2): 1303-1308

CGP 35348: a centrally active blocker of GABAB receptors. European Journal of Pharmacology 187(1): 27-38

CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma. Advances in Prostaglandin, Thromboxane, and Leukotriene Research 17b: 771-774

CGP 35949: a potent leukotriene antagonist and inhibitor of phospholipase. Biological profile. Advances in Prostaglandin, Thromboxane, and Leukotriene Research 17a: 526-531

CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity. British Journal of Pharmacology 99(4): 791-797

CGP 37849 and CGP 39551: novel competitive N-methyl-D-aspartate receptor antagonists with potent oral anticonvulsant activity. Progress in Clinical and Biological Research 361: 421-427

CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity. Journal of Cardiovascular Pharmacology 14(2): 221-226

CGP 45715 A: a leukotriene D4 analogue with potent peptido-LT antagonist activity. Advances in Prostaglandin, Thromboxane, and Leukotriene Research 21b: 503-507

CGP 4832, a new semisynthetic rifamycin derivative highly active against some gram-negative bacteria. Journal of Antibiotics 40(12): 1733-1739

CGP 6085 A, a new, specific, inhibitor of serotonin uptake: neurochemical characterization and comparison with other serotonin uptake blockers. Journal of Pharmacology and Experimental Therapeutics 211(1): 42-49

CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties. Cancer ChemoTherapy and Pharmacology 23(6): 341-347

CGP 6809--a new nitrosoureido-sugar derivative with activity in human tumor xenografts. Cancer ChemoTherapy and Pharmacology 23(6): 337-340

CGP 9000: a new orally active, broad-spectrum cephalosporin. Journal of Antibiotics 29(6): 653-655

CGRP antagonist activity of short C-terminal fragments of human alpha CGRP, CGRP(23-37) and CGRP(19-37). Peptides 13(5): 1025-1027

CGRP expression in the rat olivocerebellar system during postnatal development. Brain Research 504(2): 315-319

CGRP in relation to neurogenic inflammation and cAMP in the rabbit eye. Experimental Eye Research 47(2): 307-316

CGRP modulates nerve-mediated vasoconstriction of rat knee joint blood vessels. Annals of the New York Academy of Sciences 657: 519-521

CGRP stimulates the adhesion of leukocytes to vascular endothelial cells. Peptides 13(3): 429-434

CGRP stimulates the release of pro-somatostatin-derived peptides from the gastric fundus. American Journal of Physiology 258(2 Pt 1): G316-G319

CGRP-immunoreactive endocrine cell proliferation in normal and hypoxic rat lung studied by immunocytochemical detection of incorporation of 5'-bromodeoxyuridine. Cell and Tissue Research 268(1): 9-15

CGRP-immunoreactive nerves in the genitalia of the female rat originate from dorsal root ganglia T11-L3 and L6-S1: a combined immunocytochemical and retrograde tracing study. Neuroscience Letters 69(1): 13-18

CGRP-immunoreactive sensory nerve fibers in the submandibular gland of the rat. Histochemistry 91(6): 455-460

CGRP-like immunoreactive nerve endings in the rat knee joint. Annals of the New York Academy of Sciences 657: 484-486

CGRP-like immunoreactivity in the guinea pig organ of Corti: a light and electron microscopy study. Hearing Research 42(1): 83-95

CGRP-mediated changes in segmental resistances in the canine forelimb. Microcirculation, Endothelium, and Lymphatics 6(6): 465-481

CGRP: a novel neuropeptide from the calcitonin gene is the most potent vasodilator known. Journal of Hypertension. Supplement 4(5): S102-S105

CGS 10746B is able to attenuate the effects of amphetamine: further evidence for dopaminergic mediation. Pharmacology, Biochemistry, and Behavior 30(4): 1089-1092

CGS 10746B: an atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses. Life Sciences 39(8): 699-705

CGS 12970: a novel, long acting thromboxane synthetase inhibitor. British Journal of Pharmacology 86(2): 497-504

CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben. European Journal of Pharmacology 133(3): 265-273

CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of nontolerant and caffeine-tolerant rats. Life Sciences 49(21): 1563-1570

CGS 16949A, a new aromatase inhibitor in the treatment of breast cancer--a phase I study. Annals of Oncology 1(6): 421-426

CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo. Cancer Research 48(4): 834-838

CGS 18102A, a benzopyranopyridine anxiolytic with 5-HT1 agonist and 5-HT2 antagonist properties. Progress in Clinical and Biological Research 361: 469-475

CGS 19755 is a potent and competitive antagonist at NMDA-type receptors. European Journal of Pharmacology 154(1): 89-93

CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 246(1): 65-75

CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic properties. Progress in Clinical and Biological Research 361: 519-524

CGS 20625, a novel pyrazolopyridine with selective anxiolytic activity. Progress in Clinical and Biological Research 361: 477-482

CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. Journal of Pharmacology and Experimental Therapeutics 251(1): 47-55

CGS 22745: a selective orally active inhibitor of 5-lipoxygenase. Agents and Actions 34(1-2): 125-128

CGS 5649 B, a new compound, reverses age-related cognitive dysfunctions in rats. Behavioral and Neural Biology 57(2): 149-156

CGS 8216 and CGS 9896, novel pyrazoloquinoline benzodiazepine ligands with benzodiazepine agonist and antagonist properties. Pharmacology, Biochemistry, and Behavior 23(4): 639-644

CGS 8216 antagonizes effects of benzodiazepines on defensive-escape and other behaviour during intraspecies conflict in mice. Activitas Nervosa Superior 31(1): 61-62

CGS 8216 treatment decreases central-type benzodiazepine receptors in rat brain. European Journal of Pharmacology 142(3): 457-460

CGS 8216, a benzodiazepine antagonist, reduces food intake in food-deprived rats. Pharmacology, Biochemistry, and Behavior 24(6): 1703-1706

CGS 8216, a benzodiazepine receptor antagonist, enhances learning and memory in mice. Brain Research 460(1): 195-198

CGS 8216, a novel anorectic agent, selectively reduces saccharin solution consumption in the rat. Pharmacology, Biochemistry, and Behavior 25(2): 341-345

CGS 8216: agonist and diazepam-antagonist effects in rodents. Journal of Pharmacology and Experimental Therapeutics 239(1): 166-173

CGS 9343B and W7 (calmodulin antagonists) inhibit KCl-induced increase in cytosolic free calcium and insulin secretion of RINm5F cells. Naunyn-Schmiedeberg's Archives of Pharmacology 339(1-2): 8-13

CGS 9896 and ZK 91296, but not CGS 8216 and RO 15-1788, are pure benzodiazepine receptor antagonists on mouse neurons in culture. Journal of Pharmacology and Experimental Therapeutics 242(1): 48-55

CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents. Journal of Pharmacology and Experimental Therapeutics 235(1): 98-105

CGS-12970, a thromboxane synthetase inhibitor, limits ischemic damage following coronary artery occlusion. Research Communications in Chemical Pathology and Pharmacology 52(3): 285-294

CGS-19755 and MK-801 selectively prevent rat striatal cholinergic and gabaergic neuronal degeneration induced by N-methyl-D-aspartate and ibotenate in vivo. Journal of Neural Transmission. General Section 78(3): 183-193

CGS-19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia. Annals of Neurology 27(6): 612-619

CGVD workshop: should Haemophilus influenzae type B conjugate vaccines be introduced into the EPI?. Lancet 339(8796): 802-803

CH isotype switching in B cell differentiation. Biochemical Society Symposium 51: 159-172

CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors. Journal of Pharmacology and Experimental Therapeutics 238(2): 701-706

CH2 and CH3 domain deleted IgG1 paraproteins inhibit differently Fc receptor mediated binding and cytolysis. Immunology Letters 12(5-6): 307-312

CH3 domain of IgG as binding site to Fc receptor on mouse lymphocytes. Nature 253(5493): 656-656

CH50, C'2 and C'3 levels in patients of tuberculosis--a preliminary study. Indian Journal of Pathology & Microbiology 20(4): 243-249

CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients. Vutreshni Bolesti 26(4): 66-70

CHA AIDS video now complete. Dimensions in Health Service 67(5): 8-8

CHA and continuing care. Dimensions in Health Service 67(5): 5-6, 26

CHA and the goals of witness. Hospital Progress 59(9): 81-85

CHA as an ecclesial community. Hospital Progress 59(12): 40-44

CHA board acts on all Study Committee recommendations: report of the CHA Board of Trustees meeting. Hospital Progress 59(5): 24, 24a-24c

CHA board meeting: board approves Mission Statement; refers it to Bylaws Committee. Hospital Progress 59(10): 25, 28-25, 28

CHA brief proposes national health council. Dimensions in Health Service 56(5): 6-6

CHA negotiates a 21% primary layer reduction. Modern Healthcare 8(12): 48-48

CHA revises Catholic Health Assembly purpose; studies regional meetings. Hospital Progress 60(10): 18-9, 20

CHA survey of central management services organizations. Hospital Progress 60(8): 26, 28, 30-26, 28, 30

CHA's new CEO. Interview by Henrik Andersen. Dimensions in Health Service 67(1): 7-7

CHAMPUS Partnership Program. Military Medicine 154(11): 583-583

CHAMPUS and APA join forces to develop a model system of peer review. Hospital & Community Psychiatry 28(12): 914-915

CHAMPUS coverage. American Journal of Psychiatry 135(4): 509-510

CHAMPUS guidelines for Missouri physicians. Missouri Medicine 89(11): 782-783

CHAMPUS payment limitations. American Journal of Psychiatry 135(10): 1247-1247

CHAMPUS plans Oct. 1 start-up of DRG system. Hospitals 61(14): 18, 22-18, 22

CHAMPUS speaks on diagnosis of adolescents and third-party payors. Journal - National Association of Private Psychiatric Hospitals 8(1): 13-17

CHAMPUS ten-state claim experience for mental disorder: fiscal year 1975. American Psychologist 32(9): 697-710

CHAP II therapy for epithelial ovarian cancers following primary treatment with platinum-based combination chemotherapy. Gynecologic Oncology 25(3): 340-346

CHAP: America's most achievable health care reform. Nursing & Health Care 13(6): 283-283

CHAP: nursing's legacy of leadership. Nursing & Health Care 13(6): 296-7, 299-302

CHAPS solubilization of a G-protein sensitive 5-HT1A receptor from bovine hippocampus. Life Sciences 45(21): 1997-2005

CHAR proposal makes state less fertile ground to recruit young smokers. Journal of the Arkansas Medical Society 88(12): 611-614

CHAR succeeds in petition goal. Journal of the Arkansas Medical Society 89(3): 138-139

CHARGE and Joubert syndromes are different. Pediatric Neurology 7(4): 310-310

CHARGE and Joubert syndromes: are they a single disorder?. Pediatric Neurology 6(6): 428-430

CHARGE association in neonates presenting with choanal atresia. Zeitschrift für Kinderchirurgie 42(1): 12-13

CHARGE association: paralysis or facial asymmetry?. Pediatrie 45(9): 625-625

CHARGE syndrome. Part I. External ear anomalies. International Journal of Pediatric Otorhinolaryngology 12(2): 137-143

CHARGE syndrome. Part II. Hearing loss. International Journal of Pediatric Otorhinolaryngology 12(2): 145-163

CHARGE-association with pulmonary stenosis. Acta Paediatrica Scandinavica 77(6): 918-919

CHARGE: consortium of hospital and rehabilitative geriatric enterprises. Bulletin of the Medical Library Association 67(1): 59-61

CHARTLINE: providing bibliographic references relevant to patient charts using the UMLS Metathesaurus Knowledge Sources. Proceedings. Symposium on Computer Applications in Medical Care: 86-90

CHD and its risk factors: the pooling project. Lakartidningen 76(24): 2286-2288

CHD risk factors in the elderly. Hospital Practice 11(10): 113-121

CHD risk factors: a Framingham study update. Hospital Practice 25(7): 119-27, 130

CHD, MI, & I. The story of a 57-year love-hate relationship. North Carolina Medical Journal 50(10): 567-570

CHE1 UF serum cholinesterase phenotype in whites and non-whites from southern Brazil as determined by a new method. Human Heredity 41(2): 103-106

CHEC: statewide implementation for Medicaid. Journal of the Medical Association of Georgia 64(7): 261-263

CHEF electrophoresis, a sensitive technique for the determination of DNA double-strand breaks. International Journal of Radiation Biology 56(4): 437-448

CHEMLEARN: microcomputer-based training for CHEMLINE, an alternative to formal classroom training. Journal of Chemical Information and Computer Sciences 30(1): 48-52

CHEMTREC and PSTN. Bulletin ): 3-3

CHESS: a computer-based system for providing information, referrals, decision support and social support to people facing medical and other health-related crises. Proceedings. Symposium on Computer Applications in Medical Care: 161-165

CHF, rales, and the Dco. Chest 98(3): 523-524

CHF: reflections on current management of the older patient. Geriatrics 41(9): 71-3, 76-8, 81

CHID: a unique health information and education database. Bulletin of the Medical Library Association 75(2): 95-100

CHID: a useful alternative to MEDLINE. Diabetes Educator 12(1): 60-61

CHILD + ILVEN = PEN or PENCIL. Journal of Medical Genetics 27(6): 390-391

CHILD syndrome--a case report for understanding this rare genetic dermatosis. Dermatologische Monatschrift 175(2): 100-106

CHILD syndrome: fibroblasts from involved skin fail to proliferate in response to interleukin 1a due to induction of excessive prostaglandin E2 synthesis. Advances in Prostaglandin, Thromboxane, and Leukotriene Research 21b: 835-838

CHILD syndrome: lack of expression of epidermal differentiation markers in lesional ichthyotic skin. Journal of Investigative Dermatology 98(4): 442-449

CHIME--a concise hospital information management enquiry. Australasian Physical & Engineering Sciences in Medicine 11(1): 21-26

CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity. Journal of Clinical Oncology 9(8): 1421-1425

CHO cell mutants for arginyl-, asparagyl-, glutaminyl-, histidyl- and methionyl-transfer RNA synthetases: identification and initial characterization. Cell 11(1): 157-168

CHO cell repair of single-strand and double-strand DNA breaks induced by gamma- and alpha-radiations. Basic Life Sciences 5b: 665-676

CHO cells synthesize amidated neuropeptide Y from a C-peptide deleted form of the precursor. Endocrinology 129(1): 553-555

CHO mutant UV61 removes (6-4) photoproducts but not cyclobutane dimers. Mutagenesis 4(2): 140-146

CHOP and COPBLAM chemotherapy for diffuse large cell non-Hodgkin's lymphomas: a retrospective comparison. Hematological Oncology 6(1): 13-19

CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma. Important Advances in Oncology: 217-225

CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia. Nouvelle Revue Francaise D'hematologie 30(5-6): 449-452

CHOP treatment of childhood acute myelogenous leukemia with monocytic differentiation: a report on five cases. Haematology and Blood Transfusion 30: 403-405

CHOP versus CNOP (N = mitoxantrone) in non-Hodgkin's lymphoma: an interim report comparing efficacy and toxicity. Haematologica 73(3): 217-222

CHOP versus prednisolone + chlorambucil in chronic lymphocytic leukemia (CLL): preliminary results of a randomized multicenter study. Nouvelle Revue Francaise D'hematologie 30(5-6): 433-436

CHOP vs MEV for the treatment of non-Hodgkin's lymphoma of unfavourable histopathology: a randomized clinical trial. European Journal of Cancer & Clinical Oncology 21(2): 175-179

CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes & Development 6(3): 439-453

CHOP-Bleo in advanced non-Hodgkin malignant lymphoma. Blood 50(5): 962-963

CHOP-bleo versus m-BACOD in the treatment of intermediate and high-grade malignant lymphomas. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 42(4): 271-276

CHOP-firstline treatment in NHL with unfavorable prognosis--evaluation of therapeutic response and factors influencing prognosis. Blut 50(5): 267-276

CHORD operators for cell-survival models and insult assessment to active bone marrow. Radiation Research 71(2): 269-283

CHROMINFO: a database for viewing and editing top-level chromosome data. Proceedings. Symposium on Computer Applications in Medical Care: 366-370

CHRONOS: a data base management package for physicians and researchers. Computer Programs in Biomedicine 6(3): 149-165

CHRPE in non-Gardner's familial polyposis coli patients. Ophthalmology 96(3): 399-400

CHS's White: his focus is on hospitals. Hospitals 60(21): 44-44

CHSLP pastoral care model. Hospital Progress 56(1): 48-53

CHanging direction in nursing education. Giving and supervising primary health care. Taehan Kanho. Korean Nurse 16(4): 68-71, 67

CHaracteristics of speech hearing under conditions of speech disturbance. Vestnik Otorinolaringologii: 25-30

CHox E, a chicken homeogene of the H2.0 type exhibits dorso-ventral restriction in the proliferating region of the spinal cord. Mechanisms of Development 35(1): 13-24

CI-719 in hyperlipoproteinaemia: interim data. Proceedings of the Royal Society of Medicine 69 Suppl 2: 83-87

CI-744 anesthesia for ophthalmological examination and surgery in monkeys. Investigative Ophthalmology 14(10): 788-791

CI-867, a new broad-spectrum semisynthetic penicillin. Journal of Antibiotics 32(6): 621-625

CI-921: an analog of amsacrine with experimental activity against solid tumors. Investigational New Drugs 4(2): 113-118

CI-922--a novel, potent antiallergic compound--I. Inhibition of mediator release in vitro. International Journal of Immunopharmacology 9(1): 41-49

CI-922--a novel, potent antiallergic compound--II. Activity in animal models of allergy. International Journal of Immunopharmacology 9(1): 51-60

CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacology. Journal of Pharmacology and Experimental Therapeutics 238(2): 473-479

CI-930, a new cardiotonic and vasodilating agent: hemodynamic comparison to dobutamine and long-term clinical effects. American Heart Journal 116(4): 1008-1016

CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria. Diagnostic Microbiology and Infectious Disease 6(3): 185-192

CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects. Journal of Pharmacology and Experimental Therapeutics 251(1): 105-112

CI-943, a potential antipsychotic agent. II. Neurochemical effects. Journal of Pharmacology and Experimental Therapeutics 251(1): 113-122

CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity. Journal of Pharmacology and Experimental Therapeutics 251(1): 123-130

CI-949: a new, potential antiallergy compound inhibits antigen-induced allergic reactions in guinea-pigs in vitro and in vivo. Pulmonary Pharmacology 3(4): 203-208

CI-959, a new, potential antiallergic drug, inhibits mediator release from lung and contractions of human airways in vitro. International Archives of Allergy and Applied Immunology 93(2-3): 267-271

CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum. Diagnostic Microbiology and Infectious Disease 15(2): 169-171

CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis. Antimicrobial Agents and ChemoTherapy 36(6): 1192-1197

CI-973, a new platinum derivative with potential antileukemic activity. Cancer Research 52(15): 4130-4134

CI-977, a novel and selective agonist for the kappa-opioid receptor. British Journal of Pharmacology 101(1): 183-189

CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat. British Journal of Pharmacology 105(3): 591-596

CIBA award for hypertension research 1987 to Donald J. Reis. Hypertension 11(6 Pt 2): 767-767

CICIAMS Study group on family life. Nouvelles - Comite International Catholique des Infirmieres et Assistantes Medico-Sociales. News - International Committee of Catholic Nurses and Medico-Social Workers: 11-24

CICIAMS XIII World Congress, Lisbon, 1986. Third Round Table--'Rights of Health Personnel'. Journal of the Catholic Nurses Guild of England and Wales: 4-10

CICIAMS XIIIth World Congress. Why this theme: health personnel and human rights?. Nouvelles - Comite International Catholique des Infirmieres et Assistantes Medico-Sociales. News - International Committee of Catholic Nurses and Medico-Social Workers: 12-17

CICIAMS XIV World Congress New York. Perennial ethical and moral values in a changing society. Journal of the Catholic Nurses Guild of England and Wales: 16-19

CICIAMS and the "critical situation" in nursing. Nouvelles - Comite International Catholique des Infirmieres et Assistantes Medico-Sociales. News - International Committee of Catholic Nurses and Medico-Social Workers: 1-4

CIDNP detected flash photolysis of cis-syn 1,3 dimethylthymine dimer. Photochemistry and Photobiology 44(2): 137-142

CIDNP in tyrosyl protons of luliberin. Nature 271(5646): 685-686

CIE detection of bacterial antigens in meningitis. Journal of Pediatrics 90(4): 676-677

CIEP with cellogel (cellulose acetate membrane) in the diagnosis of visceral leishmaniosis. Annali Sclavo; Rivista di Microbiologia E di Immunologia 21(1): 93-99

CIG 'Pulsealert' modification. Anaesthesia and Intensive Care 17(2): 236-236

CIN (cervical intraepithelial neoplasia)--a challenge?. Zentralblatt für Gynakologie 112(3): 121-122

CIN 3: the role of lesion size in invasion. British Journal of Obstetrics and Gynaecology 99(7): 583-586

CIN and pregnancy, a 20-year retrospect. Geburtshilfe und Frauenheilkunde 52(3): 139-143

CIN--what influence do smoking and socioeconomic factors have?. Zentralblatt für Gynakologie 113(17): 923-926

CINA: a software to Compose INfusion sheets for i.v. Anesthetic drugs. International Journal of Clinical Monitoring and Computing 8(3): 225-229

CINAHL and MEDLINE: a comparison of indexing practices. Bulletin of the Medical Library Association 77(4): 366-371

CINAHL list of subject headings: a nursing thesaurus revised. Bulletin of the Medical Library Association 73(2): 153-159

CINNews. Computers in Nursing News. Nursing Times 82(36): 59-67

CIOs have limited say in business planning. Hospitals 62(4): 92, 94-92, 94

CIRD symposium: Advances in skin pharmacology VI: Toxicity after topical application. 4-6 October 1985, Sophia Antipolis, France. British Journal of Dermatology 115 Suppl 31: 1-149

CIRSE '92: annual meeting of the Cardiovascular and Interventional Radiological Society of Europe. Barcelona, Spain, August 30-September 3, 1992. Abstracts. Cardiovascular and Interventional Radiology 15 Suppl: S1-76

CIS sponsor debate flawed. Nursing 5(1): 4-4

CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck. Cancer Treatment Reports 61(3): 359-366

CISOC-SARSS: a versatile structure-activity relationship study system. Progress in Clinical and Biological Research 291: 97-100

CIT International Scientific Colloquium. 'Toxicology of pesticides--present and future--national and international views'. 29th November 1988, Paris, France. Food Additives and Contaminants 6 Suppl 1: S1-133

CITECH--the new mark of excellence. Health Devices 17(9): 251-252

CK MB versus total CK in the estimation of myocardial necrosis. Comparative kinetic analysis and evaluation of an immunological method. Giornale Italiano di Cardiologia 7(6): 552-562

CK and ASAT: comparative evaluation as prognostic indicator in acute myocardial infarction. Indian Journal of Chest Diseases & Allied Sciences 27(3): 159-163

CK and LDH increase in paroxysmal tachycardia?. Deutsche Medizinische Wochenschrift 103(37): 1430-1430

CK anomaly. Rinsho Byori. Japanese Journal of Clinical Pathology 34(4): 402-403

CK isoenzymes in chronic kidney failure. Deutsche Medizinische Wochenschrift 104(9): 311-311

CK-BB isoenzyme detected by radioimmunoassay. Annals of Neurology 4(6): 576-577

CK-MB and implanted defibrillator. American Heart Journal 116(6 Pt 1): 1658-1659

CK-MB assay in the Ames Seralyzer. Clinical Chemistry 32(4): 701-701

CK-MB assay specificity. Clinical Chemistry 34(12): 2607-2607

CK-MB determination. Unusability of the selective activation technic using dithiothreitol. Das Medizinische Laboratorium 31(7): 166-172

CK-MB in acute myocardial infarct. Bollettino Della Societa Italiana di Cardiologia 24(3): 339-345

CK-MB is sufficient as a specific marker in the diagnosis of myocardial infarction. Lakartidningen 88(36): 2890-2892

CK-MB isoenzyme in the diagnosis of myocardial infarction after myocardial revascularization surgery. Annales Francaises D'anesthesie et de Reanimation 7(5): 370-376

CK-MB isoform determination and early diagnosis of myocardial infarction. Clinical Chemistry 36(6): 1255-1256

CK-MB mass--a reliable marker for diagnosis of myocardial infarction. Lakartidningen 89(17): 1452-1453

CK-MB-isoenzyme activity in suicidal drug poisoning. Verhandlungen der Deutschen Gesellschaft für Innere Medizin: 1527-1530

CK-MB: a valuable test?. Annals of Clinical Biochemistry 23: 238-242

CK-MB: determination and interpretation. L'union Medicale du Canada 115(10): 723-9, 744

CK-MM interference with an immunoenzymometric method for quantification of CK-MB in serum. Clinical Chemistry 35(5): 901-902

CK-isoenzyme activity in cerebrospinal fluid as a marker of central nervous system pathological process. Zeitschrift für Medizinische Laboratoriumsdiagnostik 27(4): 179-185

CKBB-enzyme activity in serum in neonates born after vaginal delivery and cesarean section. Neuropediatrics 18(3): 146-148

CKBB-isoenzymes as a sign of cerebral injury. Acta Neurochirurgica. Supplementum 28(1): 108-112

CKM carcinogenesis models. Journal of the National Cancer Institute 82(21): 1723-1724

CL 218-872 pretreatment and intervention block kainate-induced convulsions and neuropathology. Behavioral Neuroscience 102(1): 84-92

CL 277,082: a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption. Journal of Lipid Research 30(5): 681-690

CL 287,110 and CL 286,558. Cancer Investigation 7(5): 537-537

CL 64,855, a potent anti-Trypanosoma cruzi drug, is also mutagenic in the Salmonella/microsome assay. Memorias do Instituto Oswaldo Cruz 81(1): 49-52

CL regression in the pseudopregnant rabbit and the effects of treatment with prostaglandin F-2alpha and arachidonic acid. Journal of Reproduction and Fertility 53(2): 381-387

CL-proteins and the regulation of lipoprotein lipase activity in locust flight muscle. Biological Chemistry Hoppe-Seyler 367(11): 1127-1133

CL. Separation of catechol estrogens by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography 178(1): 350-354

CLAO, contact lens reclassification and the FDA: who is the patient's advocate?. Clao Journal 14(3): 120, 122-120, 122

CLEARVIEW Chlamydia test for detection of chlamydiae in cervical specimens. Journal of Clinical Microbiology 30(8): 2216-2216

CLEP--college credit for experience. Dental Assistant 46(4): 34-34

CLIA '88. More misguided regulation, or a promise of quality?. Archives of Pathology & Laboratory Medicine 116(7): 679-680

CLIA 1988: impact on diabetes care. Diabetes Care 15(11): 1814-1817

CLIA should classify WBC count as 'waived'. Minnesota Medicine 75(6): 8-8

CLIA: has its time finally arrived?. American Journal of Medical Technology 44(5): 496-470

CLINFO: a friendly computer from NIH. JAMA 240(19): 2037, 2040-2037, 2040

CLINITRON Therapy: is it effective?. Geriatric Nursing 8(3): 120-124

CLIX: a search algorithm for finding novel ligands capable of binding proteins of known three-dimensional structure. Proteins 12(1): 31-41

CLL and diffuse histiocytic lymphoma in one patient: clonal proliferation of two different B cells. Scandinavian Journal of Haematology 20(1): 29-36

CLO in Meckel's diverticula. Journal of Clinical Pathology 43(1): 86-87

CLO-Tests for the demonstration of Campylobacter pylori. Deutsche Medizinische Wochenschrift 112(22): 902-903

CLONING: a microcomputer program for cloning simulations. Gene 65(1): 111-116

CLONTECH now offers glyceraldehyde 3-phosphate dehydrogenase (G3PDH) and transferrin receptor PCR amplimers and cDNA probes. Nature 355(6360): 571-571

CLR (Committee on Labor Relations) group to study contracts in the NHS. Nursing Standard 387): 1-1

CLS femoral component. Orthopedics 12(9): 1195-1200

CLUSTAL V: improved software for multiple sequence alignment. Computer Applications in the Biosciences 8(2): 189-191

CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene 73(1): 237-244

CLWB Myfyrwyr Coleg dental school of Cardiff. Eds Magazine 1): 9-13

CLearance of calcium pyrophosphate dihydrate crystals in vivo. II. Studies using triclinic crystals doubly labeled with 45Ca and 85Sr. Arthritis and Rheumatism 22(10): 1122-1131

CLq precipitin in the sera of patients with allergic vasculitis (Gougerot-Ruiter Syndrome). Journal of Investigative Dermatology 64(2): 113-118

CM 40907: a structurally novel anticonvulsant in mice, rats and baboons. Journal of Pharmacology and Experimental Therapeutics 233(3): 836-844

CMA 1977-78 directory. Canadian Medical Association Journal 117(9): 1085, 1087-8

CMA 1984-85 directory. Canadian Medical Association Journal 132(2): 196-200

CMA Code of Ethics: time for a change!. Cmaj 144(7): 855-857

CMA Committee on Ethics members ask themselves: should we initiate bioethical studies?. Canadian Medical Association Journal 120(6): 715-715

CMA Policy Summary. Confidentiality, ownership and transfer of medical records. Canadian Medical Association Journal 133(2): 142a-142b

CMA and Telecom Canada to study effectiveness of iNet 2000. Canadian Medical Association Journal 132(11): 1308-1310

CMA and other members of lobby group develop five-point plan for Canada's health care future. Cmaj 146(4): 591-592

CMA archives: keeping history alive. Cmaj 134(6): 648-649

CMA booklet to help doctors, health care workers deal with AIDS. Cmaj 140(10): 1187-1187

CMA counterattack on myth of health costs begins to show success. Canadian Medical Association Journal 119(3): 262-262

CMA databank contains a wealth of information on MDs, practice patterns. Cmaj 146(12): 2241-2243

CMA issues brief on cannabis to Senate committee; calls for process to 'decriminalize' offence. Canadian Medical Association Journal 112(4): 503-4, 507

CMA issues call for action to deal with malpractice insurance "crisis". Cmaj 135(2): 145-149

CMA joins academic and research groups to seek facts and principles in biomedical research. Canadian Medical Association Journal 121(11): 1518-9, 1522, 1524

CMA launches bicycle-helmet campaign, hopes to reduce roadside carnage. Cmaj 144(11): 1498-1499

CMA leadership conference: MDs must recognize that resources are limited. Cmaj 140(8): 960-965

CMA makes a stand on professional rights for physicians. Canadian Medical Association Journal 121(7): 966-972

CMA needling leads to changes in federal drug-devices bill. Cmaj 140(5): 544-545

CMA opposes the Medicare restrictions contained in Bill C-68. Canadian Medical Association Journal 113(8): 802a-802d

CMA policy review on abortion. Canadian Medical Association Journal 119(7): 807-808

CMA policy summary on smoking and health. Cmaj 133(6): 545-546

CMA policy summary. Induced abortion. Cmaj 139(12): 1176a-1176b

CMA president-elect will apply Mennonite principles. Cmaj 135(3): 230-231

CMA takes debate about health care south of the border. Cmaj 142(7): 754-755

CMA task force presents report on continuing medical education. Canadian Medical Association Journal 112(9): 1119-1127

CMA warns MDs, patients: be cautious when taking drugs across border. Cmaj 139(3): 250-251

CMA will launch major strategic planning exercise, board decides. Cmaj 140(2): 210-211

CMA's code of ethics. Cmaj 143(7): 613-614

CMA's investment funds. Cmaj 141(6): 514-514

CMA's new director of health services continues clinical work with AIDS patients. Cmaj 144(2): 203-204

CMA's policy summaries. Cmaj 133(8): 723-723

CMA's response to abortion bill. Cmaj 142(6): 515-516

CMA-run courses for MDs sign of changing times in health care management. Cmaj 146(5): 748-750

CMAJ's first issue. Cmaj 142(10): 1103-1103

CMAJ: 75 years as the voice of the profession. Cmaj 135(12): 1405-1408

CMDNJ--the freshman class. Journal of the New Jersey Dental Association 47(4): 15-16

CME accreditation. Chest 93(6): 1314-1315

CME and MSNJ. New Jersey Medicine 86(9): 688-689

CME articles--format and evaluation. Journal of the American Academy of Dermatology 1(2): 147-149

CME associated with ECCE and ICCE. Ophthalmic Surgery 19(9): 676, 678-676, 678

CME at USA College of Medicine. Journal of the Medical Association of the State of Alabama 49(5): 6-7

CME by self-assessment. Journal of the Medical Association of the State of Alabama 47(2): 38-39

CME credit hours for ophthalmologists. Annals of Ophthalmology 8(9): 1023-1023

CME ethics, continued. Iowa Medicine 80(3): 135-135

CME for credit. Journal of the Tennessee Medical Association 83(1): 34-35

CME in Florida: an historical overview. Journal of the Florida Medical Association 74(7): 522-524

CME reexamined. Southern Medical Journal 80(4): 411-413

CME requirements for continued licensure. Medical Times 107(8): 71-74

CME teleconferences. Journal of Medical Education 62(9): 785-786

CME--the government, universities and colleges. Medical Journal of Australia 157(7): 491-492

CME-Minnesota 1977-1978. Minnesota Medicine 61(1): 54-56

CME: regulating one's state of grace. Rocky Mountain Medical Journal 76(2): 59-59

CME: should MDs be forced to go back to school?. Cmaj 141(11): 1181-1183

CME: the goal, improved patient care. Virginia Medical 103(12): 894-895

CME: "what's the gripe?". Wisconsin Medical Journal 78(3): 12-12

CMGs and DRGs: can they further improve efficiency?. Dimensions in Health Service 62(8): 40-41

CMHC emergency services in the 1980's: effects of funding changes. Community Mental Health Journal 25(4): 267-275

CMHC standards. Hospital & Community Psychiatry 39(7): 788-788

CMHC's and elderly services: an analysis of direct and indirect services and service delivery sites. Community Mental Health Journal 22(4): 294-302

CMHC's: relationships with academia and the state. Community Mental Health Journal 23(4): 271-281

CMHCs: muted impact. Hospital & Community Psychiatry 39(3): 318-319

CMI description of pathogenic fungi and bacteria. Mycopathologia 96(3): 171-196

CMI descriptions of pathogenic fungi and bacteria No. 931. Acremonium acutatum. Mycopathologia 100(3): 169-170

CMI descriptions of pathogenic fungi and bacteria No. 934. Acremonium falciforme. Mycopathologia 100(3): 175-176

CML with autoimmune thrombocytopenia observed in the course of IgG (kappa) type monoclonal gammopathy. Japanese Journal of Clinical Hematology 33(5): 706-708

CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia. Blood 74(4): 1381-1387

CML: new biologic therapies, endpoints and questions. Oncology 1(7): 12-3, 16

CMOS integrated circuits. Biomedical Instrumentation & Technology 23(3): 240-242

CMP-KDO-synthetase activity in Escherichia coli expressing capsular polysaccharides. Fems Microbiology Letters 57(1-2): 129-133

CMP-N-acetylneuraminic acid hydrolase, an ectoenzyme distributed unevenly over the hepatocyte surface. Biochimica et Biophysica Acta 466(1): 187-197

CMP-N-acetylneuraminic acid hydroxylase activity determines the wheat germ agglutinin-binding phenotype in two mutants of the lymphoma cell line MDAY-D2. Glycoconjugate Journal 8(5): 434-441

CMP-N-acetylneuraminic acid synthetase of Escherichia coli: high level expression, purification and use in the enzymatic synthesis of CMP-N-acetylneuraminic acid and CMP-neuraminic acid derivatives. Glycobiology 1(2): 187-191

CMP-NeuNAc:poly-alpha-2,8-sialosyl sialyltransferase and the biosynthesis of polysialosyl units in neural cell adhesion molecules. Journal of Biological Chemistry 260(23): 12695-9

CMP-NeuNAc:poly-alpha-2,8-sialosyl sialyltransferase in neural cell membranes. Methods in Enzymology 138: 627-637

CMP-sialic acid, the sole sialosyl donor, is intra-axonally transported. Febs Letters 192(2): 239-242

CMPA and Jehovah's Witness. Canadian Journal of Anaesthesia 38(2): 262-263

CMR studies of protein modification. Progressive decrease in charge density at the epsilon-amino function of lysine with increasing methyl substitution. Biochemical and Biophysical Research Communications 64(2): 514-518

CMR-70--a new cancer-environment registry available for research. Lakartidningen 86(32-33): 2661-2662

CMS challenged on (pro-choice) resolution 23P. Colorado Medicine 86(13): 212-212

CMS/ERF reaches around the world. Colorado Medicine 84(19): 441-443

CMSS-VEP: contrast modulated steady state visual evoked potentials. A functional examination technique of the visual system. Bulletin de la Societe Belge D'ophtalmologie 215: 27-36

CMSS-VEPs: contrast modulated steady state visual evoked potentials: its neuronal origin and clinical use. Documenta Ophthalmologica. Advances in Ophthalmology 68(3-4): 363-374

CMV antibody determination with two enzyme immunoassays in each case. Beitrage Zur Infusionstherapie 26: 40-42

CMV antigenemia as diagnostic tool for diagnosing active cytomegalovirus infection. Bone Marrow Transplantation 7 Suppl 2: 45-45

CMV colitis in an immunocompetent adult. Journal of the Royal Society of Medicine 85(4): 238-239

CMV colitis mimicking Crohn's disease in a patient with acquired immune deficiency syndrome (AIDS). Canadian Association of Radiologists Journal 38(3): 227-228

CMV immunoglobulin for prevention of pneumonitis after BMT. Bone Marrow Transplantation 3(3): 235-236

CMV in pregnancy case report and review of literature. Jpma. Journal of the Pakistan Medical Association 39(9): 246-247

CMV infection in patients with chronic renal failure and in those following transplantation. Czechoslovak Medicine 11(3): 131-136

CMV infection in young women. Hospital Practice 25(3a): 61-5, 69, 72-9

CMV infection modulates interleukin-6 production in human bone marrow stroma cells. Bone Marrow Transplantation 7 Suppl 2: 152-152

CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 42(4): 364-367

CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin). Folia Haematologica 116(3-4): 557-564

CMV pneumonia and response to ganciclovir treatment in an AIDS patient. Respiratory Medicine 85(5): 437-439

CMV polyradiculopathy in AIDS--suggestions for new strategies in treatment. Genitourinary Medicine 68(3): 192-192

CMV prophylaxis in allogeneic BMT with ganciclovir and CMV immune globulin. Bone Marrow Transplantation 7 Suppl 2: 44-44

CMV reinfection/reactivation after liver transplantation. Transplantation Proceedings 23(5): 2632-2633

CMV retinitis. British Medical Journal 2(6043): 1071-1071

CMV retinitis in AIDS--a pre-final complication?. Klinische Monatsblatter für Augenheilkunde 198(5): 447-450

CMV retinitis treated with ganciclovir [9(1,3-dihydroxy-2-propoxymethyl) guanine] in patients with AIDS. Annals of Ophthalmology 19(10): 369-73,375

CMV screening with the latex agglutination test in blood donors. Comparison between EIA and latex agglutination. Beitrage Zur Infusionstherapie 26: 43-45

CMV vaccine: a response to criticism. Hospital Practice 13(9): 18, 24-18, 24

CMV virus infection of the vulva and vagina. Geburtshilfe und Frauenheilkunde 50(9): 729-730

CMV, HIV, and the pancreas. Lancet 2(8613): 748-748

CMV-induced augmentation of GVL effect may be mediated by cytokines. Bone Marrow Transplantation 7(1): 69-69

CMV-specific polymeric and monomeric IgA antibodies in serum of renal transplant patients. Panminerva Medica 33(4): 173-179

CNA PAC: political power for nurses. California Nurse 88(4): 4-5

CNA Testing Service. Canadian Nurse 75(5): 44-45

CNA action on RCT proposal. California Nurse 84(9): 3-3

CNA backs state AIDS legislation. California Nurse 83(8): 4-4

CNA bill passes; nursing scholarship program established. California Nurse 84(7): Suppl 3-Suppl 3

CNA candidates' statements of interest. California Nurse 85(5): 6-7

CNA continues to lead in AIDS education. California Nurse 85(7): 6-7

CNA fights encroachment on nursing practice. California Nurse 84(7): Suppl 5-Suppl 5

CNA heard on project iatrogenesis. California Nurse 74(4): 1, 6-1, 6

CNA joins campaign for alcohol tax initiative. California Nurse 86(4): 6-6

CNA members present research findings at Korea conference. California Nurse 86(2): 8-9

CNA opposes new move to mandate HIV testing. California Nurse 88(4): 5-5

CNA opposes unsafe staffing patterns. California Nurse 88(3): 1, 12-1, 12

CNA rates decrease for professional liability. Lda Journal 47(2): 20-21

CNA takes case against RCTs to CMA meeting. California Nurse 85(4): 7-7

CNA testifies on AIDS. California Nurse 83(10): 1, 6-1, 6

CNA wins respiratory care decision. California Nurse 84(7): 6-6

CNA's peer assistance network for nurses. Connecticut Nursing News 59(4): 1-2

CNA-synthesis in gamma-platlets of wheat. Zeitschrift für Naturforschung. Section C, Biosciences 30(2): 300-301

CNBr cleavage of the light chain of human complement factor I and alignment of the fragments. Biochemical Journal 233(2): 339-345

CNDO molecular orbital calculations on porphyrins--I. Ground and excited states of porphyrin, divinylporphyrin and tetraphenylporphyrin. Bioinorganic Chemistry 7(4): 283-296

CNDO molecular orbital calculations on porphyrins--II. Ground states of dilithium and disodium porphyrin. Bioinorganic Chemistry 7(4): 297-301

CNDO/2 conformational analysis of acetylselenocholine. Journal of Theoretical Biology 66(4): 811-814

CNDO/2 study of the conformational properties of the tricyclic antidepressants. Experientia. Supplementum 23: 185-191

CNE--a model for shared education. Cooperative Nursing Education. Nursing Management 19(5): 90, 92-90, 92

CNEP--a pilot Community-Based Nurse-Midwifery Education Program. Frontier Nursing Service Quarterly Bulletin 65(1): 1-4

CNIB mobile medical eye care units in Canada. I. Newfoundland Mobile Eye Care Unit. Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie 10(3): 335-341

CNIB mobile medical eye care units in Canada. II. Quebec Mobile Eye Care Unit. Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie 10(3): 341-342

CNIB mobile medical eye care units in Canada. III. Ontario Mobile Eye Care Unit. Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie 10(3): 342-343

CNIB mobile medical eye care units in Canada. IV. Role of the CNIB Eye Service Nurse. Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie 10(3): 343-345

CNJ talks to Lois Dale, PHN. Canadian Nurse 75(1): 39-40

CNM/MD relations. Cultivating mutual respect. Journal of Nurse-Midwifery 37(2): 81-83

CNO and CEO decision-making patterns and compatability: Part 2, Using the MBTI. Journal of Nursing Administration 19(1): 15-20

CNP respirator of own construction--preliminary experience. Ceskoslovenska Pediatrie 32(9): 569-569

CNP-22 stimulates, rather than inhibits, water drinking in the rat: evidence for a unique biological action of the C-type natriuretic peptides. Brain Research 568(1-2): 285-288

CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) antagonizes NMDA-evoked [3H]GABA release from cultured cortical neurons via an inhibitory action at the strychnine-insensitive glycine site. Brain Research 489(1): 185-189

CNQX and DNQX block non-NMDA synaptic transmission but not NMDA-evoked locomotion in lamprey spinal cord. Brain Research 506(2): 297-302

CNQX blocks acidic amino acid induced depolarizations and synaptic components mediated by non-NMDA receptors in rat hippocampal slices. Neuroscience Letters 89(2): 182-186

CNQX, a new non-NMDA receptor antagonist, reduces spike wave discharges in the WAG/Rij rat model of absence epilepsy. Epilepsy Research 9(2): 127-131

CNR delegates make far-reaching decisions in Jamaica. International Nursing Review 38(5): 138-144

CNR enhancement in the presence of multiple interfering processes using linear filters. Magnetic Resonance in Medicine 14(1): 79-96

CNR firms up nursing's stand on critical issues. International Nursing Review 36(5): 137-40, 154

CNS - endocrine pancreas system. IV. Evidence for the existence of a direct hypothalamic-vagal descending pathway. Endokrinologie 71(2): 175-182

CNS 3-methoxy-4-hydroxyphenylglycol: its peripheral assessment by isotopic dilution and theoretical significance. Brain Research Bulletin 3(6): 669-674

CNS Lyme disease. Neurology 42(9): 1849-1850

CNS activation patterns underlying motor evoked potentials as demonstrated by c-fos immunoreactivity. Electroencephalography and Clinical Neurophysiology. Supplement 43: 155-169

CNS activity of antihistaminics. Zeitschrift für Hautkrankheiten 60 Suppl 1: 23-28

CNS adrenergic receptors and beta blockade. Postgraduate Medicine Spec No: 135-139

CNS alpha 2-adrenoceptor induced mydriasis in conscious rats. Journal of Ocular Pharmacology 6(2): 123-129

CNS and ACTH-like peptides: neurochemical response and interaction with opiates. Advances in Biochemical Psychopharmacology 17: 61-80

CNS arousal systems: possible role in delirium. International Psychogeriatrics 3(2): 353-371

CNS biochemical and pharmacological effects of the isomers of hexachlorocyclohexane (lindane) in the mouse. Toxicology and Applied Pharmacology 93(1): 146-153

CNS blockade of acoustic stress-induced gastric motor inhibition by kappa-opiate agonists in dogs. American Journal of Physiology 254(6 Pt 1): G802-G807

CNS cancers and radiation exposure: a case-control study among workers at two nuclear facilities. Journal of Occupational Medicine. 29(7): 601-604

CNS cell groups projecting to the submandibular parasympathetic preganglionic neurons in the rat: a retrograde transneuronal viral cell body labeling study. Brain Research 572(1-2): 253-260

CNS changes can be present in asymptomatic HIV infection. Lakartidningen 88(47): 4004-4005

CNS changes in hyperbilirubinemia. Functional implications. Archives of Neurology 36(3): 149-154